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ABSTRACT 
 
Liposomal formulations are often lyophilized because aqueous formulations are 
prone to degradation (e.g., aggregation, oxidation and hydrolysis). The lipid-based 
products which are commercially available utilize hydrogenated, saturated or singly 
unsaturated lipids. Although polyunsaturated lipids are more prone to oxidative 
degradation, they have been shown to be more fusogenic which promotes endosomal 
escape after liposomes have been endocytosed by cells. Endosomal escape is critical to 
prevent the lysosomal degradation of liposomes and increased endosomal escape has 
been correlated with the increased delivery of siRNA and luceriferase silencing.  
In this work, we investigated the stability of lyophilized formulations containing 
unsaturated lipids. Specifically, we focused on characterizing the degradation of a triply 
unsaturated lipid, DLPC, during lyophilization and the storage stability of lyophilized 
formulations containing PC phospholipids which were singly (18:1), doubly (18:2) or 
triply (18:3) unsaturated. In samples spiked with ferrous ion, DLPC degradation occurred 
during the freezing stage of lyophilization and the degradation increased as the ferrous 
ion concentration was increased. DLPC degradation was increased when low ionic 
strength conditions were induced during freezing (e.g. relatively higher sugar 
concentrations). The effect of ionization state of the iron contaminants in the sugar (i.e., 
Fe
+3
 form) was also evaluated by adding sodium sulfite, a reducing agent, to DLPC 
iv 
 
samples. Significant DLPC degradation was only observed in samples which contained 
sucrose and sodium sulfite suggesting that the more reactive Fe
+2
 ion was generated. In 
the study which examined the long term stability of lyophilized liposomal formulations, it 
was observed that degradation increased as the degree of lipid unsaturation and the 
storage temperature were increased. The observed DLPC degradation was not dependent 
upon the state of the amorphous sugar matrix (e.g., glass or rubber) however the addition 
of iron chelators dramatically improved the stability of DLPC samples. It was shown that 
although the iron contaminants present in the sugar did not affect lipid stability during 
lyophilization, these contaminants increase the degradation of lyophilized DLPC 
formulations during storage. These results demonstrate the potential role of trace metal 
contaminants in lipid degradation during prolonged storage, and underscore the 
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Liposomes are vesicles that are composed of phospholipids which are cationic, 
anionic and/or neutral. The delivery of small molecules using lipid based delivery 
vehicles has led to the development of a number of commercial liposomal products. 
1
 The 
liposomal products which are currently available commercially are composed of 
saturated, hydrogenated or singly unsaturated lipids due to their greater chemical 
stability. Although our focus is on the chemical stability of lipids in pharmaceutically 
relevant experimental systems, other studies have investigated the stability of lipids in 
relation to food and beverage products 
2-8
  
The main degradation pathways that are of concern for liposomal formulations are 
peroxidation and hydrolysis. Peroxidation, which is a complex free radical mediated 
process, consists of three distinct steps: initiation, propagation and termination. 
9,10
 
Peroxidation initiation involves the abstraction of a hydrogen atom from the fatty acid tail 
of a lipid resulting in the formation of lipid radicals. The ease with which the hydrogen 
can be abstracted is related to the number of unsaturated sites in the fatty acid tail of the 
lipid. The carbon-hydrogen bond energy is decreased for allylic (88 kcal/mol) and 
bisallyic (75-80 kcal/mol ) carbon-hydrogen bonds relative to alkyl carbon-hydrogen 
bonds (101 kcal/mol). (Figure 1.1) 
11
 The decreased bond energy as well as the 
resonance stabilization of the resulting lipid radical underlies the greater propensity of 
lipids containing two or more unsaturated sites to undergo peroxidation. 
9,12




Figure 1.1: Depiction of the lipid fatty acid tail illustrating the carbon hydrogen bond 
energies. 
 
propagation, the reaction of molecular oxygen with a lipid radical results in the formation 
of peroxyl radicals. 
12
 Once formed, the peroxyl radical can then abstract a hydrogen 
atom from another lipid molecule leading to the formation of hydroperoxides and lipid 
radicals. 
12
 In addition to these reactions, a number of other reactions such as 
fragmentation, rearrangement and cyclization can also occur. 
12
 Termination, the final 
step of lipid peroxidation, occurs when non-radical products are formed as a result of the 
coupling of two radicals. 
13
 It has been demonstrated that peroxidation can affect the 
physical properties (i.e., permeability and fluidity) of liposomal bilayers. 
14-16
 Besides 
peroxidation, hydrolytic degradation of lipids is also of concern. The ester functionality 
which connects the glycerol backbone with the fatty acid tails is susceptible to hydrolysis 
and results in the formation of free fatty acids, lysophospholipids and glycerophospho 
compounds. 
17




Due to the limited stability of aqueous liposomal formulations, these formulations 
are often lyophilized. Little is known about the chemical stability of lyophilized 
3 
 
liposomal formulations (i.e., lipids in the dried state). Predominately the studies which 
have investigated lipid stability have focused on aqueous liposomal formulations. 
However, liposomal leakage and the retention of small molecules have been studied in 
lyophilized and aqueous formulations. 
19-21
 To better understand how to maximize the 
stability of lipids in the dried state, it is necessary to review the studies which have 
investigated the chemical stability of lipids in aqueous formulations. The continued 
development of lipid-based therapeutics necessitates the further investigation of the 




In the studies which have examined the stability of liposomal formulations, 




) catalysts or azo compounds are utilized to facilitate 
the initiation of lipid peroxidation. The various ways that transition metals can affect lipid 
peroxidation has been studied extensively and several possibilities have been proposed. 
The reaction of iron with oxygen and/or hydrogen peroxide via the Haber-Weiss and/or 
the Fenton reactions results in hydroxyl radical formation which can initiate peroxidation. 
22,23
 It is well known that the direct reaction of O2 with lipid molecules is spin-forbidden 
due to the electronic configuration of these molecules 
24,25
 but, iron is capable of 
mitigating the spin restriction and increasing the rates of oxidation of biological 
molecules (e.g., lipids) by serving as a bridge. 
26
 Another route by which iron can affect 
lipid peroxidation is through direct initiation. Direct initiation of lipid peroxidation by 
higher valence state metals, such as Fe
3+
, via one electron transfers can lead to the 
4 
 
formation of lipid radicals.
27
 The use of azo compounds is another strategy which has 
been employed to investigate lipid peroxidation. Azo compounds, often referred to as azo 
initiators, are molecules which decompose leading to the generation of radicals. Azo 
compounds vary in terms of the efficiency with which they generate radicals and their 
propensity to reside in the lipid bilayer or in aqueous solution. 
28
 Because of the 
difficulties that have been encountered when using traditional azo compounds (e.g., 
AAPH, AMVN) to investigate lipid peroxidation, significant research has been conducted 
to synthesize and characterize azo compounds that reside and generate radicals in the 
lipid bilayer efficiently. 
28,29
 Although many studies have endeavored to determine the 
factors that play a role in the oxidative degradation of aqueous liposomal formulations, 
this chapter focuses on reports which have investigated the effect of lipid unsaturation, 
inclusion of cationic or anionic lipids, and the use of antioxidants. 
 
Aqueous Liposomal Formulations 
 
Effect of Lipid Unsaturation and Cholesterol 
The effect of the particular lipids incorporated into the liposomes has been 
examined as well as the effect of the addition of cholesterol. Mowri et al. 
30
 investigated 
the peroxidation of liposomes composed of either POPC (16:0, 18:1) or PAPC (16:0, 
20:4) in the presence of iron (II) and ascorbic acid. POPC was expected to be insensitive 
to peroxidation. Conversely, PAPC was expected to undergo peroxidation due to the 
presence of a polyunsaturated fatty acid, arachidonic acid, at the sn-2 position. The 
thiobarbituric acid reactive substances (TBARS) assay, which detects secondary products 
5 
 
(i.e., aldehydes), was utilized along with gas chromatography (GC) to assess changes in 
the fatty acid content. Analysis of the PAPC samples showed an increase in aldehyde 
products with a concomitant decrease in arachidonic acid. In contrast, the formation of 
aldehyde products was not detected in POPC liposomes, and no detectable change in the 
fatty acid content was observed. 
30
 The effect of mixing PAPC with different 
peroxidation insensitive lipids, POPC (16:0, 18:1) or DSPC (18:0), was also assessed. For 
the PAPC:POPC formulation (1:9 mole ratio) the concentration of aldehyde products 
detected was negligible however a significant concentration of aldehyde products was 
detected for the PAPC:DSPC (1:9) formulation. Analysis of the arachidonic acid fatty 
acid content revealed no detectable change in the arachidonic acid content for the 
PAPC:POPC (1:9) liposomes, however for the PAPC:DSPC (1:9) liposomes a significant 
decrease in the arachidonic acid was detected. This study was conducted at 37°C, which 
is above the liquid crystalline-to-gel transition temperature for both POPC and PAPC. 
Mowri et al. 
30
 suggested that POPC and PAPC were homogeneously distributed in the 
bilayer and the distance between the PAPC molecules decreased peroxidation. Further 
Mowri et al. 
30
 suggested that PAPC and DSPC would not be homogeneously distributed 
in the bilayer. Because the liquid crystalline-to-gel transition temperature of DSPC is 
greater than the temperature at which this study was conducted, DSPC would be expected 
to be in the gel state resulting in the clustering of PAPC. Thus, the increased peroxidation 
of PAPC was attributed to the greater density of PAPC molecules when formulated with 
a gel phase lipid like DSPC.  
Vossen et al. 
31
 investigated the copper (II)/H2O2 catalyzed peroxidation of 
liposomes containing increasing levels of unsaturation by monitoring the accumulation of 
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conjugated dienes. This study utilized liposomes composed of PLinPC, (16:0 18:2), 
PLPC (16:0 18:3) or PAPC (16:0 20:4). Since palmitic acid (16:0) is insensitive to 
peroxidation, the formation of conjugated dienes resulting from peroxidation was 
attributed to either linoleic acid (18:2), linolenic acid (18:3) or arachidonic acid (20:4). 
The experimental system in this study used only PC lipids eliminating any variation that 
would be caused from using lipids with different headgroups and is free of other 
molecules that would obscure the results (e.g., proteins). Conjugated diene formation was 
not detected in the liposomal formulations containing saturated and singly unsaturated 
lipids (16:0, 16:1 or 18:0, 18:1). However, the formation of conjugated dienes was 
detected in the formulations which contained polyunsaturated lipids and it was observed 
that the peroxidation of PLPC liposomes was more rapid relative to liposomes composed 
of PLinPC. The peroxidation of PAPC liposomes was slower than either of the other 
liposome formulations that were tested but 
31
 the underlying cause of this result was not 
discussed. 
Cholesterol which is known to increase the rigidity of the bilayer and increase 
transfection efficiency of lipid-nucleic acid complexes is often included in liposomal 
formulations. 
32-35
 Several studies which have examined the effect of cholesterol on the 
oxidative degradation of liposomal formulations have reported inconsistent results and 
the effect of cholesterol appears to depend on the composition of the liposomal 
formulation and the temperature at which the study was conducted. 
36
 While Samuni and 
Barenholz 
37
 found that the oxidative degradation of egg PC (EPC) liposomes was 
decreased when cholesterol was incorporated, Tirosh et al 
38
 found that cholesterol did 
not improve the stability of EPC liposomes and increased oxidation was observed in the 
7 
 
EPC:cholesterol formulation containing 10% cholesterol.  Despite both of these studies 
using EPC liposomes, differences in the experimental design (e.g., exposure of liposome 
samples to UV light vs use of AAPH, an azo initiator) may have contributed to the 
different observations which were reported. The decreased oxidative degradation in 
cholesterol containing formulations was attributed to a more tightly packed bilayer, 
hindrance of the free radical mediated propagation reactions and decreased bilayer 
hydration. 
37
 Tirosh et al 
38
 suggested that increased peroxidation in the formulation 
containing 10% cholesterol could be attributed to the coexistence of ordered and 
disordered lipid phases, but it is unclear why such phases would not exist at the higher 
cholesterol concentrations that did not exhibit increased peroxidation. In another study, 
that employed PAPC (16:0, 20:4) liposomes, a decrease in oxidative degradation was 
observed in formulations containing cholesterol (1:2 and 1:1 cholesterol:PAPC) and it 
was suggested that the decreased oxidation resulted from changes in the bilayer fluidity. 
30
   
 
Incorporation of Charged Lipids 
The interest in the effect of the inclusion of cationic or anionic lipids in a 
liposomal formulation is often driven by use of cationic lipids, such as DOTAP, in lipid-
based nucleic acid delivery vehicles or the desire to better understand the peroxidation of 
biomembranes which are inherently negatively-charged. A significant amount of research 
has been conducted to assess the factors which affect iron-catalyzed peroxidation of 
cationic or anionic liposomal formulations. It has been reported that the inclusion of 
anionic lipids, in particular DPPS, inhibits lipid peroxidation due to binding of the 
8 
 
cationic iron ions by the negatively-charged headgroup thereby limiting the ability of iron 
to catalyze the decomposition of lipid hydroperoxides. 
39,40
 Conversely, other have 
15
 
reported that anionic liposomes readily underwent peroxidation whereas neutral and 
cationic liposomes were less susceptible to oxidative degradation. The increased 
peroxidation of anionic liposomes was attributed to increased binding of iron ions or the 
close proximity of the ferrous ions to the surface of the bilayer. When peroxidation was 
initiated by azo compounds, the effect of the use of cationic or anionic lipids on 
liposomal peroxidation was minimal to negligible. 
39-41
    
 
Incorporation of Antioxidants 
The addition of antioxidants to liposomal formulations is a common strategy 
which is used to minimize the oxidative degradation of susceptible liposome components 
(e.g., polyunsaturated lipids) however; it has been argued that the effect of antioxidants is 
limited and insufficient to completely prevent the oxidation of polyunsaturated lipids. 
42
 
Antioxidants are typically characterized as either water-soluble (e.g., ascorbic acid, uric 
acid) or lipophilic (e.g., α-tocopherol, 2,2,5,7,8-pentamethyl-6-chromanol (PMC)).  
Noguchi et al. 
29
 examined the peroxidation of both methyl linoleate micelles and PC 
liposomes in the presence of the azo initiators, AAPH (water-soluble) or MeO-AMVN 
(lipophilic). Methyl linoleate micelle oxidation was followed by measuring the formation 
of hydroperoxides and the consumption of oxygen.  The oxidation of methyl linoleate in 
the presence of MeO-AMVN was inhibited by PMC but not by ascorbic acid. In the 
presence of AAPH, methyl linoleate oxidation was inhibited by ascorbic acid. Not 
surprisingly, methyl linoleate oxidation was inhibited effectively when the antioxidant 
9 
 
and the source of the radicals (i.e., the azo initiator) were located in close proximity either 
in the aqueous solution or the lipid bilayer. When the MeO-AMVN (lipophilic) and 
ascorbic acid (water-soluble) were added to methyl linoleate samples, oxidation was only 
inhibited when a cationic surfactant, TTAB, was also present. It was proposed that the 
electrostatic attraction between the cationic TTAB and the anionic ascorbic acid (at pH 
7.4) brought the ascorbic acid in close contact with the surface of the micelle. 
29
 Similar 
experiments were carried out to examine the peroxidation of PC liposomes in the 
presence of antioxidants. 
29
 The peroxidation of PC liposomes was initiated by the 
addition of MeO-AMVN and the ability of several antioxidants to inhibit peroxidation 
was tested. PC liposome peroxidation, which was monitored by measuring the formation 
of lipid hydroperoxides, was decreased most efficiently in the presence of the 
antioxidants (e.g., PMC) that were able to efficiently partition into the bilayer 
29
 We have 
observed related phenomena when using fluorescent probes to monitor lipid oxidation.  
In our previous studies on lipid oxidation, we observed that water-soluble probes were 




Lyophilized Lipid Formulations 
Particularly in the 1960s and 70s, an increased interest in the stability of freeze-
dried food products arose. A number of studies were conducted that focused on the 
factors that would deleteriously impact the stability of lyophilized food products. These 
studies focused on lipid peroxidation in lyophilized foods and a variety of experimental 
systems were used to investigate the effect of moisture content, transition metals and 
antioxidants. Interested readers are referred to several studies 
2-8
 which utilized 
10 
 
lyophilized salmon and dehydrated milk as well as an experimental system comprised by 
methyl linoleate, cellulose and glycerol to study lipid oxidation.  However, because of the 
significant differences and complexity in these experimental systems, this work will not 
be discussed.  
Years later, an insightful study conducted by Mouradian et al. 
44
 investigated the 
chemical stability of lipid-based vesicles over the course of 49 days.  Sarcoplasmic 
reticulum (SR) vesicles prepared from lobster tail muscle were isolated and lyophilized. 
These vesicles were not a pure lipid system and contained proteins inherent to the 
sarcoplasmic reticulum.  The oxidative degradation of these lipid-based vesicles was 
assessed by measuring the accumulation of lipid hydroperoxides and secondary oxidation 
products (i.e., aldehydes) with the TBARS assay. Oxidation was expected to be a major 
degradation pathway due to the presence of polyunsaturated lipids in the sarcoplasmic 
reticulum membrane. The effect of varying the concentration of trehalose (0 to 2 gram 
trehalose/gram membrane) was tested and it was observed that the trehalose content of 
SR vesicle samples had no effect on oxidation.  However, the moisture content, which 
was dictated by the relative humidity samples were exposed to during storage (0% and 
35%), and exposure to light had significant effects on the stability of the SR vesicles. As 
might be expected, exposure to light correlated with increased hydroperoxide 
accumulation.  Surprisingly, a greater concentration of secondary oxidation products was 
detected in the samples with lower moisture content (exposed to 0% relative humidity).  
Mouradian et al. 
44
 proposed that the secondary oxidation products were less stable 




In chapter II, the chemical stability of a triply unsaturated lipid, DLPC (18:3), in a 
lyophilized formulation was investigated. This work specifically focused on the oxidative 
degradation of DLPC during lyophilization. 
45
 Iron (II) was added to the DLPC-sucrose 
samples to mimic the trace transition metal contaminants that are known to be present in 
the pharmaceutical-grade sugars that are used as lyoprotectants. During lyophilization, 
DLPC peroxidation occurred during the freezing step and the DLPC peroxidation 
increased as the iron (II) concentration was increased. It was determined that the DLPC 
peroxidation occurred during the freezing process, and did not continue while the DLPC 
samples were maintained in the frozen state. The concentration of sucrose in DLPC 
samples as well as the buffer ionic strength also affected DLPC stability. Increasing the 
sucrose concentration caused a decrease in the buffer ionic strength in the freeze 
concentrate which increased DLPC peroxidation. The effect of the buffer ionic strength 
on DLPC stability was confirmed by conducting an experiment in samples which were 
stored at 4°C overnight and the buffer ionic strength was increased in these samples to 
mimic the freeze concentrated state encountered during the freezing step of 
lyophilization. Considering that iron ions are known to interact with lipid bilayers (i.e., 
liposomes and microsomes) through electrostatic interactions with the negatively charged 
phosphate in the lipid headgroup 
46
, the increased concentration of ions (in our case, 
ionized Tris molecules and chloride ions) may inhibit interactions that promote lipid 
degradation. Alternatively, the reduced DLPC degradation may be due to the formation 
of iron–chloride complexes which decreased the iron–lipid interactions; previous studies 
have shown that chloride ions can reduce iron-catalyzed lipid oxidation 
47-50
. Another 
potential explanation involves the Tris salts playing a more direct role in decreasing 
12 
 
DLPC peroxidation. In this regard, it is important to note that Tris has been reported to 
react with hydroxyl radicals formed during lipid peroxidation to a greater extent than 
fatty acids, such as linoleate. 
51
 It was also observed that the addition of Na2SO3, a 
reducing agent, to DLPC-sucrose samples when exogenous iron was not added 
significantly increased the DLPC degradation. These results are consistent with the 
suggestion that the sugar used in the formulation possesses trace quantities of iron (III) 
contaminants such that addition of Na2SO3 undergoes redox with the sucrose–Fe
+3
 
complex to produce iron (II) and/or displaces the iron (III) species which then undergo in 




In chapter III, the long term storage stability of lyophilized unsaturated lipid 
formulations was studied. (NM Payton, manuscript in preparation) Formulations 
containing DLPC (18:3), DLinPC (18:2) and DOPC (18:1) were utilized to examine the 
effect of liposome composition. DLPC, DLinPC and DOPC were lyophilized in a 
trehalose formulation and stored at 4°C, room temperature, 37°C, 50°C and 60°C. 
Degradation of the singly-unsaturated lipid, DOPC, was not observed at any of the 
temperatures which were studied. However, degradation of DLinPC and DLPC occurred 
and the rate of degradation increased with increasing temperature. Consistent with studies 
which utilized aqueous liposomal formulations, the rate of degradation was dependent on 
the level of lipid unsaturation.  
11,31,52,53
 The helper lipids, cholesterol and DOPE, were 
incorporated into the DLPC-trehalose formulation to examine the effect on DLPC 
stability. The rate of DLPC degradation in the formulations containing DOPE or 
cholesterol was nearly equivalent to the DLPC only formulation.  The effect of utilizing 
13 
 
different lyoprotectants (i.e., sugars) on the storage stability of DLPC (18:3) samples was 
also evaluated. It was hypothesized that the rate of degradation for the DLPC-sugar 
samples would correlate with the glass transition temperature of the sugars, and that the 
samples lyophilized in trehalose (122.0 ± 0.1°C), sucrose (60.6 ± 0.03°C) and sorbitol (-
5.4 ± 0.1°C) would exhibit slow, intermediate and fast degradation rates, respectively. 
54,55
 However, the rate of DLPC degradation in samples containing trehalose was slightly 
faster whereas the rate of DLPC degradation in samples containing sucrose and sorbitol 
was comparable.  This result suggests that the physical state of the amorphous matrix 
(e.g., glass or rubber) does not significantly affect the rate of DLPC degradation. The 
effect of adding an iron chelator, DTPA or deferoxamine, on DLPC stability was also 
evaluated, and it was observed that DLPC degradation was significantly reduced in 
samples containing a chelator. Presumably, the reactivity of the iron contaminants, which 
are known to be present in the sugars used as lyoprotectants, was reduced as a result of 
chelation.    
 
Hydrolysis- Aqueous Liposomal Formulations 
 
The hydrolysis of lipids leads to the formation of lysophospholipids and fatty 
acids. 
17
 The carboxy esters which form the connection between the glycerol backbone 
and the fatty acid tails are most susceptible to hydrolytic degradation. Lysophospholipids 
can also be further hydrolyzed leading to the formation of glycerophospho compounds 
and fatty acids. 
17
  Hydrolysis can be acid- or base- catalyzed. Although several studies 
have examined the factors that affect the hydrolysis of lipids in aqueous formulations, it 
14 
 
is difficult to compare the results due to the use of different liposomal systems and 
conditions. Temperature, pH and the use of charged lipids are the factors which have 




Effect of pH 
Several studies have looked at the effect of pH on the hydrolysis of aqueous 
liposomal formulations.  The hydrolysis of DPPC-DOPE (16:0, 18:1) and DOTAP-DOPE 
(18:0, 18:0) liposomes was evaluated as the pH was increased from 4 to 9. A distinct 
trend was observed indicating that the rate of hydrolysis was minimized between pH 5.6 
and 6.7 for all of the formulations which were investigated. 
56
 Another study also 
examined the effect of pH on the rate of hydrolysis using partially hydrogenated egg 
phosphatidylcholine (PHEPC) liposomes. Consistent with the results reported by 
Vernooij et al., 
56
 the rate of hydrolysis was slowest for PHEPC liposomes at 
approximately pH 6.5. 
17
 Ho et al. 
57
 also examined the rate of hydrolysis using POPC 
(16:0/18:1) liposomes at pH 1, 4, 7, and 10. Contrary to results reported by Vernooij et al. 
and Grit et al., where increased hydrolysis at pH 4 was observed, Ho et al. 
57
 observed 
that the hydrolysis of POPC only occurred at an appreciable rate at pH 1. The underlying 
reasoning regarding the occurrence of hydrolysis only at pH 1 was not discussed. 
Instead of varying the pH and examining the effect on the rate of hydrolysis, 
Kensil and Dennis 
58
 focused on base-catalyzed hydrolysis of egg PC liposomes at pH 
12.7. The ability of hydroxide ions to access the ester bond, which connects the glycerol 
backbone to the fatty acids, was examined by measuring the rate of hydrolysis when the 
EPC bilayer was perturbed. A non-ionic surfactant (Triton X-100) was spiked into EPC 
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samples to perturb the bilayer. As the Triton X-100:EPC molar ratio and the resulting 
bilayer perturbation was increased, small increases in the rate of hydrolysis were 
observed. The effect of increasing the fatty acid chain length was investigated by 
measuring the rate of hydrolysis for DLaPC (12:0), DMPC (14:0) and DPPC (16:0) 
Triton X-100-PC liposomes (8:1). It was observed that the fatty acid chain length did not 
have a significant effect on the rate of hydrolysis. The effect of the varying the lipid 
headgroup was also investigated. To eliminate any variation caused by a difference in the 
fatty acid tails, PE lipids were prepared from EPC via transesterification. The hydrolysis 
of PC liposomes was three times faster than PE liposomes, which was attributed, in part, 
to the overall neutral and anionic charge of the PC and PE liposomes respectively at pH 
12.7. The electrostatic repulsion between the anionic PE liposomes and the hydroxide 
ions was thought to contribute to the lower hydrolysis rate although the differences in 
packing of the PC and PE molecules in the bilayer and the penetration of the bilayer by 
solvent molecules may also have contributed to the different hydrolysis rates.  The 
authors also investigated the positional specificity of hydrolysis using 
14
C radiolabeled 
DPPC (16:0) liposomes, and the hydrolysis of the palmitic acid tails was evaluated below 
and above the liquid-to-crystalline gel transition temperature (40°C). Hydrolysis of the 
fatty acids at the sn-1 and the sn-2 positions was not significantly different and the 
physical state of the DPPC bilayer (liquid crystalline or gel) did not preferentially 








Inclusion of Charged Lipids 
DOTAP is a cationic lipid that is often utilized in liposome formulations, 
especially those which are intended to deliver nucleic acid therapeutics. The effect of the 
incorporation of DOTAP into a liposomal formulation on the rate of hydrolysis was 
evaluated by comparing DOTAP-DOPE (18:0, 18:0) liposomes with liposomes 
composed of the zwitterionic/neutral lipids, DPPC-DOPE (16:0, 18:1), at pH 7.0. 
56
 An 
increased rate of hydrolysis was observed for both lipids in the DOTAP-DOPE 
formulation. The increased rate of hydrolysis for liposomes containing DOTAP was 
attributed to increased accessibility of ester linkage between the glycerol backbone and 
the fatty acid tails thereby promoting hydroxyl-catalyzed hydrolysis. 
56
 The effect of the 
incorporation of an anionic lipid, egg phosphatidylglycerol (EPG), into a partially 
hydrogenated egg phosphatidylcholine (PHEPC) liposomal formulation has also been 
investigated. An increased rate of hydrolysis was observed for EPG-PHEPC (10:4) 
liposomes relative to pure PHEPC liposomes, particularly in the pH range of 4 to 6.5. 
59
 
The increased hydrolysis rate for EPG-PHEPC liposomes was attributed to an 
accumulation of protons at the lipid bilayer-water interface leading to increased acid-
catalyzed hydrolysis. 
59
 To our knowledge there are have been no studies which have 
examined the hydrolytic degradation of lyophilized liposomal formulations.  Admittedly, 
such a study would be very difficult to perform at the low water contents (≈ 1%) typical 







LYOPHILIZATION OF A TRIPLY UNSATURATED PHOSPHOLIPID: 






Liposomal delivery systems have been used to improve the delivery of small 
molecule pharmaceuticals; there are currently twelve liposomal products on the market 
1
. 
In the case of liposomal formulations designed to deliver siRNA, unsaturated lipids have 
proven superior to saturated lipids for promoting intracellular nucleic acid delivery 
60-63
. 
Unfortunately, unsaturated lipids are highly susceptible to being oxidized which limits 
their use in lipid-based commercial products. As liquid liposomal formulations are prone 
to chemical degradation and aggregation, these formulations are often lyophilized to 
achieve stability compatible with a marketable product. Furthermore, the increased 
immunogenicity associated with the use of viral vectors and the resulting safety concerns 
underscore the need to further develop non-viral delivery systems 
64-66
. Liposomal vectors 
also have the potential to provide a possible avenue for the treatment of diseases that are 
not responsive to existing therapeutics. Tuberculosis, for example, has become 
increasingly difficult to treat due to a significant increase in drug resistant strains 
67
. 
While the use of liposomes to deliver small molecule drugs to treat tuberculosis (e.g., 
Rifampicin) appears promising, the technology has not been fully developed 
68
. Hence, 
                                                          
1
 This chapter is published with permission from Payton N, Wempe M, Betker J, 
Randolph T, Anchordoquy T 2013. Lyophilization of a triply unsaturated phospholipid: 
Effects of trace metal contaminants. European Journal of Pharmaceutics and 
Biopharmaceutics  85(2):306-313. 
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additional research efforts to improve stability and efficiency of liposomal delivery 
systems are needed.   
The chemical and physical stability of aqueous liposomal formulations, which 
have been studied extensively, are limited due to the occurrence of peroxidation, 
hydrolysis and aggregation 
37,69
. It has been shown that as the number of unsaturated 
bonds increases, the extent of peroxidation also increases 
37
. The decreased bond 
dissociation energy at the carbon-hydrogen bonds in the bis-allylic position underlies the 
increased oxidizability of polyunsaturated lipids 
11,70
. Previous studies have assessed 
oxidative lipid degradation by measuring aldehyde products, conjugated dienes, 
hydroperoxides and/or oxygen consumption 
71,72
.  
One common approach to improve the overall stability of liposomal formulations 
is freeze-drying (i.e., lyophilization).  Lyophilization of liposomes often incorporates the 
use of sugars, such as sucrose or trehalose, which form glassy matrices that limit mobility 
(vitrification hypothesis), forms hydrogen bonds (water replacement theory) and/or 
separates the individual liposomes (particle isolation hypothesis) 
73-76
. Even in the case of 
pharmaceutical-grade sugars, the presence of transition metal contaminants is a concern. 
Transition metals, such as iron, can catalyze the oxidative degradation of unsaturated 
lipids in the dried state and may also lead to co-degradation of liposomal cargo (e.g., 
DNA degradation) 
77,78
. Saturated and hydrogenated lipids are less prone to oxidative 









. Singly unsaturated lipids such as 1,2-dioleoyl-
sn-glycero-3-phosphocholine (DOPC) are also less susceptible to oxidative degradation 







. Although polyunsaturated lipids are significantly more susceptible to 
oxidative degradation, the use of these lipids in liposomal pharmaceutical preparations is 
being investigated. Recently, it was demonstrated that lipids with two or more 
unsaturations were more fusogenic relative to lipids with fewer unsaturated bonds, and 
this promotes endosomal escape 
60
.  The requirement for endosomal escape is a major 
hindrance when delivering nucleic acids to the interior of the cell. Furthermore, the 
increased endosomal escape has been shown to correlate with increased siRNA delivery 
and luciferase silencing in vitro 
60
.  
In the current study, we have utilized a triply unsaturated lipid, DLPC, and 
evaluated the acute degradation occurring during lyophilization. While lyophilization is 
generally a strategy to minimize the degradation of liposome formulations, the 
lyophilization process exposes liposomal formulations to freezing and drying stresses 
79-
81
. We investigated the effects of sugar (i.e. sucrose, trehalose or hydroxyethyl starch) 
and ferrous ion concentration on DLPC degradation during lyophilization. In an attempt 
to mimic transition metal contaminants known to be present in pharmaceutical-grade 
sugars, we spiked ferrous ion into the DLPC samples at iron levels that are commonly 
found in pharmaceutical-grade sugars 
82,83
.   Although the effect of transition metals, such 
as ferric and ferrous ions, on the oxidative degradation of lipids has been studied, a 
significant proportion of  studies which examined iron catalyzed lipid peroxidation were 
focused on the stability of consumable foods and the progression of various diseases 
53,84,85
.  We believe this to be the first study to address the stability of pharmaceutically-




Materials and Methods 
 
Materials 
1, 2-Dilinolenoyl-sn-glycero-3-phosphocholine (DLPC; 18:3 (Cis) PC) (>99%, 
Lot # 183-12li) was purchased from Avanti Polar Lipids (Alabaster, AL).  Sucrose 
(Ultrex
©
 ultrapure, Lot # J25H00) was purchased from JT Baker (Center Valley, PA). 
Trehalose (100%, Lot # 28549A) was purchased from Ferro Pfanstiehl (Waukegan, IL). 
Hydroxyethyl starch (HES, Batch # 17081421) was purchased from Fresenius Kabi 
(Linz, Austria). 5-(2-Carboxyphenyl)-5-hydroxy-1-((2, 2, 5, 5-tetramethyl-1-
oxypyrrolidin-3-yl) methyl)-3-phenyl-2-pyrrolin-4-one potassium salt (proxyl 
fluorescamine) was obtained from Molecular Probes, Inc. (Eugene, OR). Tris 
[hydroxymethyl] amino-methane, iron (II; ferrous ion) chloride tetrahydrate, 2-
thiobarbituric acid (TBA), 2,6-di-tert-butyl-4-methylphenol (BHT), 1,1,3,3-tetraethoxy 
propane (MDA), sodium sulfite and hydrochloric acid were purchased from Sigma-
Aldrich Chemical Company (St. Louis, MO). 3-(2-Pyridyl)-5, 6-diphenyl-1, 2, 4-triazine-
p, p’-disulfonic acid, disodium salt hydrate (ferroZine iron reagent) and propionic acid 
were purchased from Acros Organics (Geel, Belgium). Trichloroacetic acid 10% w/v 
aqueous solution was purchased from Ricca Chemical Company (Arlington, TX). 
Chloroform, methanol, water, (all of which were HPLC grade), LC/MS grade acetone, 
ascorbic acid and Eppendorf tubes (1.5 mL) were procured from Fisher Scientific 
(Pittsburgh, PA). High grade helium and nitrogen were purchased from Airgas (Radnor, 
PA). Amber glass vials (5 mL) were procured from West Pharmaceutical Services 
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(Lionville, PA). Phenomenex Strata X solid phase extraction (SPE) tubes (1.0 mL) 
containing sorbent (30 mg; Lot # S300-139) were used (Torrance, CA).  
 
DLPC Sample Preparation 
The lipid (DLPC) stock, originally dissolved in chloroform (10.0 mg/ml), was 
concentrated using a slow stream of nitrogen. The lipid was then further dried under 
vacuum (559 torr) for approximately one hour. The lipid (DLPC) was then suspended in 
Tris buffer (0.5 mM, pH 7.4) to afford a final DLPC concentration of 0.1 mg/ml. The 
rehydrated lipid (DLPC) was then sonicated (30 sec) and vortex mixed (5 sec). The 
resulting DLPC liposome suspension was used immediately after additional dilution with 
Tris buffer to 0.04 mg/ml. Stock aqueous ferrous ion solutions (400 ppm) were prepared 
immediately before use in HPLC grade water (Fisher Scientific W5-4); this stock solution 
was then diluted and added into the study samples. Sucrose, trehalose and HES were 
initially prepared as 10% w/v solutions in Tris buffer (0.5 mM, pH 7.4). The sugars were 
added to the samples such that the final sugar concentration was 2.0%. The final samples 
(1.0 mL) were prepared in amber glass vials (5 mL) and contained 0.01 mg/ml DLPC, 
2% sugar (sucrose, trehalose or HES), and 0.0 ppm, 0.2 ppm or 1.0 ppm ferrous ion. In 
the experiments evaluating the effect of the oxidation state of the transition metal 
contaminants, stock sodium sulfite solution was freshly prepared in 0.5 mM Tris buffer 
and samples prepared as described previously to contain sodium sulfite (2.0 µg/ml). 
When the effects of buffer ionic strength were tested, samples were also prepared as 
described above except that the concentrations of buffer, ferrous ion, and DLPC lipid 
were increased to mimic the concentrations in the frozen state. The volume of the freeze 
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concentrate was calculated to determine to what extent the sample solutes were 
concentrated in the frozen state 
54
. These samples were stored at 4 ± 1°C overnight. 
 
Lyophilization Protocol 
Sample vials were placed directly on the shelf of an FTS Durastop lyophilizer 
(Stone Ridge, NY). The lyophilization cycle involved freezing samples to -30°C (8 h, 
cooled at 0.4 °C/min) and the pressure of the chamber was reduced to 30-60 mTorr. Next, 
the primary drying occurred at -20°C (15 h, 2 °C/min), the secondary drying occurred at 
30°C (30 h, 1 °C/min) and then at 35°C (1.5 h, 1 °C/min). Sample temperatures were 
monitored by inserting a thermocouple into a representative sample prior to starting the 
lyophilization cycle. When samples were removed during freezing, time zero was 
considered to be 81 min after the shelf temperature had reached -30°C; at this point the 
sample temperature was stable. After sample lyophilization was completed, the vials 
were stoppered while the chamber remained under vacuum. 
 
HPLC-UV Analysis 
To measure DLPC, a Shimadzu analytical HPLC system (LC-20AB, DGU-20A, 
CTO-20A, Sil-20A HT) equipped with SPD-20A UV-VIS detector was used (Shimadzu 
Scientific Instruments, Inc.; Columbia, MD). An Aligent zorbax extended-C18 50 x 4.6 
mm (5 micron) column equipped with a guard column was used (Santa Clara, CA). The 
column temperature was maintained at 40 
o
C with a flow-rate was 0.4 mL/min. An 
isocratic method (20 min run time; 19:1 methanol:water mobile phase) was used, and UV 
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detection was monitored at 205 nm.  A 10 µL volume was injected for both samples and 
standards.  
 
Solid Phase Extraction Procedure 
Analysis of DLPC degradation products via GC/MS required the removal of the 
sugar component; a solid phase extraction (SPE) procedure was implemented. SPE was 
accomplished immediately after rehydrating lyophilized DLPC-sugar samples in 0.05 M 
HClaq. The SPE tubes were initially conditioned with acetone (1.0 mL) and equilibrated 
with HClaq (0.05M; 1.0 mL). Next, the sample was loaded onto the SPE device and 
washed using HClaq (0.05M; 1.0 mL). Using a 1.0 mL plastic syringe, air was pushed 
through the SPE device to expel any remaining solution retained in the SPE resin. 
Acetone (1.0 mL) was used to elute degradation products which were subsequently 
analyzed via GC/MS. An internal standard solution, propionic acid diluted in acetone, 
was freshly prepared and spiked into samples to afford a final concentration of 5.0 µg/ml.  
 
GC/MS Analysis 
A Shimadzu GC/MS-QP2010 Plus gas chromatograph mass spectrometer 
(Shimadzu Scientific Instruments, Inc.; Columbia, MD) was used to monitor DLPC 
degradation products. The GC2010 was equipped with a Phenomenex ZB-FFAP column 
(30m x 0.25mm x 0.25 mm). To prevent accumulation of non-volatile molecules within 
the analytical column, a 5 meter guard column (Phenomenex, Torrance, CA) was used in 
tandem with the analytical column. The settings were as follows: column temperature 
was initially set at 50 
o
C with an injector temperature of 250 
o





C for 6.0 min and then ramped at 8 
o
C min to 200 
o
C and held for 35 min. The ion 
source temperature was set at 210 
o
C and the interface at 230 
o
C. Helium was used and 
the column flow rate was 1.0 ml/min. The purge flow was 5.0 ml/min and the total flow 
was 26.1 ml/min. The pressure was 543 torr. A split ratio of 2 was utilized and the 
detector delay was set to 4.0 min. The event time was set to 0.5 sec and the scan speed 
was set to 769. The solvent cut off time was 1.0 min and the injection volume was 1.0 
µL. Three ions were specifically monitored for the propanoic internal standard (74.1, 
57.1, and 55.1) and the main product (Product A) detected in lyophilized DLPC samples 
(105.1, 122.1, and 77.0).  
 
Thiobarbituric Reactive Substances (TBARS) Assay 
The thiobarbituric acid reactive substances (TBARS) assay was utilized to 
evaluate the extent of lipid peroxidation in the samples as previously described 
86-88
. 
Freeze-dried samples were rehydrated with distilled water (1.0 mL). An aliquot (150 µl) 
of each sample was mixed with 10% trichloroacetic acid (250 µl), 2% BHT (25 µl), and 
0.67% TBA (500 µl). These mixtures were then heated at 85°C (20 min), and cooled at 
4°C (15 min). An aliquot (200 µl) from each sample was transferred into a black 
polystyrene 96-well plate and fluorescence (EX: 532 nm, EM: 550 nm) read in a 
SpectraMAX Gemini EM fluorescence microplate reader (Sunnyvale, CA). The TBARS 
concentrations were calculated from a calibration curve of fluorescence intensities from 
12 MDA standards ranging from 33.0 µM to 66.7 mM (R
2





Reactive Oxygen Species Measurement 
The fluorogenic spin-trap proxyl fluorescamine was used to detect superoxide and 
hydroxyl radicals as previously described 
89
. Proxyl fluorescamine (5.0 mg) was 
dissolved in tri-
tubes (1.5 mL). The solutions were then dried using an Eppendorf vacufuge (Hauppauge, 
NY). Immediately prior to use, the material was rehydrated to afford a final proxyl 
fluorescamine concentration of 10.3 mM. Samples were prepared as described above 
except the proxyl fluorescamine solution (4.4 µL) was added to samples prior to 
lyophilization at a final proxyl fluorescamine concentration was 45 uM. Aliquots (200 
µLs) of each sample were then transferred into a black polystyrene 96 well plate and 
analyzed using a SpectraMAX Gemini EM fluorescence microplate reader (Sunnyvale, 
CA; EX: 385nm and EM: 485 nm). 
 
Ferrozine Assay 
Ascorbic acid and ferrozine were dissolved in 1.0 M HCl so that the final 
concentrations were 200 mM and 20 mM, respectively. In experiments evaluating the 
effect of increasing the concentration of HCl on measured iron values, a concentrated 
stock of HCl (12.1 M, approximately 36%) was appropriately diluted. An aliquot (20 µL) 
of the ascorbic acid/ferrozine solution was added to each sample (340 µL), mixed and 
heated (60°C, 20 min). The reagent/sample mixture was then cooled to room temperature 
(12 hr), and the absorbance measured at 562 nm. A standard curve was generated using 






Data Analysis and Statistical Methods 
Prism 5.02
TM
 (GraphPad Software, Inc.; San Diego, CA) was used to graph and 
perform statistical analysis. The statistical differences were compared using a one-tailed 




Degradation of Lyophilized DLPC Samples 
To measure the acute degradation of DLPC from lyophilized samples, a C18 
reverse phase HPLC-UV method was developed. The HPLC-UV method was very 
reliable and DLPC could be readily quantified. For every experiment, freshly prepared 
standards containing DLPC (0.001 mg/ml to 0.1 mg/ml) were used to generate a standard 
curve. Reconstituted lyophilized samples, which varied in terms of sugar and ferrous ion 
concentration, were analyzed. The sugar (sucrose, trehalose or HES) present in the 
samples did not have a significant effect on DLPC degradation. However, the ferrous ion 
concentration significantly influenced DLPC stability. We observed that DLPC 
degradation was a function of ferrous ion concentration with approximately 101%, 67% 
and 29% of the DLPC remaining after lyophilization in samples spiked with 0 ppm, 0.2 
ppm and 1.0 ppm ferrous ion, respectively (Figure 2.1A). While the presence of sucrose 
and trehalose did not cause any complications, we found that the HPLC column was 





Analysis of DLPC Degradation Products 
We initially used the TBARS assay as an indirect method to measure DLPC 
degradation products. As summarized in Figure 2.1B, DLPC degradation products 
increased with an increase in ferrous ion concentration.  Control samples containing 
sugar and 1.0 ppm Fe
2+
 only (i.e., no DLPC) exhibited low TBARS values comparable to 
0 ppm samples, and thus degradation products arising from the sugar excipient do not 
contribute significantly to the degradation observed  in the presence of ferrous ion (data 
not shown).  In addition to measuring the DLPC degradation products formed during 
lyophilization, we were also interested in measuring DLPC degradation products formed 
during storage. When TBARS was utilized to measure DLPC degradation products from 
samples stored at 60°C, it was apparent that the products formed during storage were not 
detectable using the TBARS assay. Because the TBARS is a non-specific assay that 
measures several different lipid degradation products, and also due to the inadequacy 
mentioned above, we utilized GC/MS.  Samples required that the sugar be first removed 
using SPE preparation.  However, analogous to issues observed when conducting studies 
with the HPLC C18 column samples containing HES were not compatible with the SPE 
sample preparation protocol and therefore were not analyzed. One predominant GC/MS 
degradation product, referred herein as Product A, was observed. A representative 
chromatogram displaying the internal standard (propionic acid; tR = 16.2 min) and 
Product A (tR = 30.2 min) are depicted in Figure 2.2A.  As summarized in Figure 2.2B, 
we observed by HPLC/UV and GC/MS that as ferrous ion concentrations were 
progressively enhanced, the amount of DLPC remaining decreased, and the relative 
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amount of Product A increased. While an absolute structure has not been fully elucidated, 
we have proposed (see Appendix A) a tentative structure using GC/MS and LC/MS-MS  
data. Samples containing sucrose without spiked ferrous ion displayed essentially no 
DLPC degradation; whereas samples containing 0.2 ppm and 1.0 ppm of spiked ferrous 
ion exhibited 68% and 29% of the initial DLPC, respectively.  
 
Figure 2.1: Degradation of lyophilized DLPC samples containing ferrous ion. A- 
Measurement of DLPC remaining in lyophilized samples. Increasing DLPC degradation 
was observed as the ferrous ion concentration increased. The values represent the mean 
±1 SEM of triplicate or quadruplicate determinations. * indicates statistical significance. 
p < 0.0001   B- TBARS measurement of degradation products in lyophilized samples. 
Increased product concentrations were detected as the concentration of ferrous ion 
increased. The values represent the mean ±1 SEM of triplicate or quadruplicate 





Figure 2.2: Measurement of DLPC degradation products using GC/MS. A- 
Representative chromatogram depicting the peaks corresponding to the internal standard 
(propionic acid; tR = 16.2 min) and ‘Product A’ (tR = 30.2 min). B- Loss of DLPC (solid 
line, error bars are smaller than the symbols) and accumulation of Product A (dotted line) 
as the ferrous ion concentration is increased. 
 
Effect of Freezing and Drying on DLPC Degradation 
As we wanted to establish the influence that each lyophilization stage (i.e., 
freezing, primary drying, or secondary drying) had on DLPC stability, DLPC samples 
were removed from the lyophilization chamber after freezing, primary drying and 
secondary drying. We observed that approximately 100%, 50% and 27% of the DLPC 
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remained after freezing samples (8 hours) containing 0 ppm, 0.2 ppm and 1.0 ppm 
ferrous ion, respectively (Figure 2.3). After the freezing phase, we did not observe any 
statistically significant DLPC loss during the primary or secondary drying phases (data 
not shown).  We next sought to address if relative amounts of DLPC degradation that 
occurred during the cooling (i.e., freezing stage) was a function of the freezing process 
and/or a function of the amount of time spent in the frozen state prior to proceeding to the 
primary drying phase. We did not observe any statistically significant DLPC loss with 
time (monitored at 4, 8, 24, 48 and 72 hr post freezing) once the samples had reached the 
frozen state (data not shown).  Hence, DLPC degradation predominantly occurs during 
the freezing stage of lyophilization.  
 
Figure 2.3: Effect of freezing on DLPC degradation. Degradation of DLPC occurred 
during freezing when samples were spiked with ferrous ion. The values represent the 







Effect of Sucrose Concentration 
To evaluate if freeze concentration was affecting DLPC degradation, we varied 
the sucrose concentration (0.5, 1.0, 2.5 and 5.0%) and the ferrous ion concentrations, but 
kept DLPC content constant.  Consequently, these experiments effectively altered the 
non-ice fraction volume; increasing sucrose concentration results in a larger non-ice 
fraction volume and thereby dilutes DLPC and ferrous ion.  Regardless of sucrose 
concentration, Figure 2.4, DLPC samples not spiked with ferrous ion were essentially 
stable.  However, samples spiked with ferrous ion displayed sucrose concentration-
dependent DLPC degradation. 
 
Figure 2.4: Effect of freeze concentration on DLPC degradation.  DLPC degradation 
increased as the sucrose concentration increased from 0.5% to 5.0% (w/v) in frozen 
samples. The values represent the mean ±1 SEM of triplicate determinations. The DLPC 
degradation of samples containing 1.0%, 2.5%, and 5.0% were compared to the samples 
containing 0.5% sucrose.  * indicates statistical significance. 0ppm p > 0.05, 0.2ppm p < 





Effect of Buffer Ionic Strength on DLPC Degradation 
We next sought to evaluate the effect of ionic strength on DLPC degradation. 
Samples containing DLPC, ferrous ion, and Tris buffer were prepared such that the 
concentrations of these components mimicked the concentrations predicted in the non-ice 
fraction of maximally freeze-concentrated samples containing 0.5% and 5.0% sucrose. It 
follows that a higher Tris buffer concentration should be associated with the samples 
containing the lower concentration of sucrose, i.e. smaller non-ice fraction volume.  
Calculations revealed that samples mimicking the extent of freeze concentration expected 
in the presence of 5.0% sucrose would have solute concentrations 17.2 times higher than 
the starting solution, with solute concentrations estimated at 172 µg/ml DLPC, 3.44 ppm 
ferrous ion, and 8.6 mM Tris. Samples mimicking the freeze concentration expected in 
0.5% sucrose solutions would have solute concentrations 170.2 times higher; sample 
solute concentrations are estimated to be 1720 µg/ml DLPC, 34.4 ppm ferrous ion, and 
86 mM Tris. These values reflect that the volume of the non-ice fraction is 10 times 
smaller in the samples containing 0.5% sucrose relative to the samples containing 5.0% 
sucrose.  
After incubating these samples at 4˚C overnight, we observed that samples having 
a greater buffer ionic strength afforded lower DLPC lipid degradation (Figure 2.5).  In 
contrast, DLPC degradation was higher in samples mimicking the 5.0% sucrose 
conditions with lower buffer ionic strength. An additional sample contained constant 
DLPC and ferrous ion concentrations (172 µg/ml and 3.44 ppm, respectively), while Tris 
buffer concentration was increased to 86 mM.  Under these conditions, significantly 
33 
 
lower DLPC degradation was observed, consistent with the notion that buffer ionic 
strength influences DLPC degradation during freezing.  
 
Figure 2.5: Effect of buffer ionic strength on DLPC degradation. DLPC samples 
containing ferrous ion, DLPC and Tris concentrations mimicking the freeze concentrated 
state. Increased buffer ionic strength decreased DLPC degradation. The values represent the 
mean ±1 SEM of triplicate determinations. * indicates statistical significance. p < 0.0001 
 
Effect of Sodium Sulfite on DLPC Degradation 




) catalyze lipid 
peroxidation (i.e. Fenton Chemistry) 
77,90-92
. As ferric ion (Fe
+3
) is more stable in air than 
Fe
+2
, the iron contaminants present in sucrose are far more likely to be in the Fe
+3 
state 
due to exposure to ambient atmosphere during processing, packaging and storage.  
Consequently, depending upon the amount of moisture present, the Fe
+3
 is likely in the 
form of iron (III) oxide-hydroxides and/or sugar iron oxide complexes. Prior to 
lyophilization and upon rehydration, these ferric ion contaminants may be undergoing in 
situ Fenton Chemistry with DLPC 
93
.  It is also well known that upon the addition of 
sodium sulfite to a solution containing Fe
+3













.  Consequently, we 
investigated DLPC degradation after freezing Tris buffer solutions containing DLPC, 
DLPC + 2% sucrose, DLPC + Na2SO3, and DLPC + 2% sucrose + Na2SO3; these 
experiments were conducted without spiking any exogenous ferrous ion.  Only when 
Na2SO3 was added to the sample containing sucrose did we observe significant DLPC 
degradation (Figure 2.6).  These results are consistent with a model where the sucrose 
used in the formulation possesses trace quantities of Fe
+3
 contaminants, and the added 
Na2SO3 participates in redox reactions with the sucrose-Fe
+3





 (i.e., a more acidic environment) and/or displaces the Fe
+3
 species, which then 
undergoes in situ redox reactions to produce the more reactive Fe
+2
 ion which ultimately 
catalyzes DLPC degradation. 
 
Figure 2.6: Reduction of the transition metal contaminants in sucrose affected DLPC 
stability. Increased DLPC degradation occurred in the presence of the reduced transition 
metal contaminants.  The DLPC degradation in samples containing sucrose and Na2SO3 
was significantly different relative to the DLPC samples containing sucrose only and 
Na2SO3 only. The values represent the mean ±1 SEM of triplicate or quadruplicate 
determinations. Error bars are not visible on the scale of the figure. * indicates statistical 




Measurement of Iron Contaminants in Pharmaceutical-Grade Sugars 
The ferrozine assay can be used to evaluate the iron contaminants in 
pharmaceutical-grade sugars. Using this assay to analyze the sucrose, trehalose and 
hydroxyethyl starch used in the current studies, we found that the amount of iron detected 
via this assay was a dependent on the amount of HClaq present during the ferrozine 
reaction; higher quantities of HClaq resulted in higher values for iron content (Figure 
2.7A).  In contrast, when aqueous iron standards were mixed with the ferrozine reaction 
in the presence of higher HClaq, the absorbance did not increase (Figure 2.7B).  
Therefore, these results are consistent with the phenomena previously observed wherein 
the production of protons (H
+
; i.e., more acidic environment) liberates Fe
+3
  from the 
sucrose-Fe
+3
 complex (e.g., sugar-iron oxide complexes) which subsequently reacts with 
the ferrozine assay reagents.
 
Figure 2.7: Measurement of iron contaminants in pharmaceutical-grade sucrose. (A) 
Increased concentrations of iron were detected in 10% sucrose solution as 
hydrochloric acid concentration was increased, n = 2.(B) Absorbance of iron standards as 








Liposomal delivery systems have been successfully utilized to deliver small 
molecule pharmaceuticals; however, one disadvantage has been that unsaturated lipids 
are highly susceptible to oxidation which limits their use in lipid-based commercial 
products. DLPC (1, 2-dilinolenoyl-sn-glycero-3-phosphocholine) is a triply unsaturated 
lipid and significantly more prone to oxidative degradation than the analogous saturated 
lipid (DSPC 1, 2-distearoyl-sn-glycero-3-phosphocholine).  Despite the ability of 
unsaturated lipids to improve intracellular delivery by promoting endosomal escape, their 
intrinsic reactivity has thus far precluded their use in marketed pharmaceutical products. 
The goal of the current study was to characterize DLPC degradation during 
lyophilization, and investigate the influence of metal contaminants in promoting 
degradation.  
After developing appropriate methods for analyzing the degradation of DLPC and 
the formation of degradation products (Figures 2.1, 2.2), we performed experiments to 
determine the stage of lyophilization during which degradation was occurring.  Our 
results demonstrate that degradation occurs almost entirely in the freezing stage (Figure 
2.3), with undetectable losses during primary and secondary drying.  Because our 
freezing protocol cools samples to temperatures very close to the Tg’ of sucrose (≈ -30˚C) 
54
, we conducted additional experiments wherein samples were frozen at -20˚C, or 
plunged directly into liquid nitrogen.  Since each of these experiments resulted in DLPC 




formation played a minimal role in lipid degradation.  Further experiments were 
performed to determine whether the concentrating effect of ice formation might create 
high concentrations of reactants that promote degradation in the non-ice fraction.  
Surprisingly, dilution of Tris-HCl, iron, and DLPC in a larger non-ice fraction resulted in 
increased degradation (Figure 2.4).  This counterintuitive result suggested that the 
increased buffer ionic strength in the freeze concentrate might play a protective role.  We 
then conducted experiments at Tris-HCl concentrations approximating that in the freeze 
concentrate to evaluate their effect on degradation in the absence of freezing (Figure 
2.5).  The results clearly demonstrate that the increased Tris-HCl buffer ionic strength has 
a stabilizing effect on DLPC.  Considering that iron ions are known to interact with lipid 
bilayers (i.e., liposomes and microsomes) through electrostatic interactions with the 
negatively charged phosphate in the lipid head group 
46
, the increased concentration of 
ions (ionized Tris molecules and chloride ions) may inhibit interactions that promote lipid 
degradation.  Alternatively, the reduced DLPC degradation may be due to the formation 
of iron-chloride complexes which in turn decreased the iron-lipid interactions; previous 
studies have shown that chloride ions can reduce iron-catalyzed lipid oxidation 
47-50
.  
Another possibility involves the Tris salts playing a more direct role in decreasing DLPC 
peroxidation.  In this regard, it is important to note that Tris has been reported to react 
with hydroxyl radicals formed during lipid peroxidation to a greater extent than fatty 
acids, such as linoleate 
51
. Experiments utilizing proxyl fluorescamine to assess the 
potential role of radicals in DLPC degradation did not detect reactive oxygen species 




observed degradation (data not shown).  Consistent with this finding, previous studies 
have asserted that ROS do not always play a significant role in lipid peroxidation 
96,97
. 
Although the effect of salts on iron-catalyzed lipid oxidation has been previously studied, 




Transition metals, such as iron ions (Fe
+2
), are known to more readily catalyze the 
peroxidation of lipids (i.e., Fenton Chemistry) if present in the reduced form 
77,90-92
. 
When ferric ion catalyzes the formation of the lipid alkyl radical, an electron is 




. The reduction of ferric ion can also occur during lipid 
hydro-peroxide decomposition  
27
 or as a result of reaction with superoxide 
99
.  We 
hypothesized that the reduction of the transition metal contaminants (e.g., iron) through 
the reactions discussed above during lipid peroxidation may allow these contaminants to 
catalyze DLPC degradation. To test this hypothesis, it was necessary to design an 
experiment where transition metal contaminants would be reduced without significantly 
altering solution pH. To the best of our ability, we wanted to avoid both acidic and basic 
conditions as they would promote lipid hydrolysis. As sodium sulfite is known to reduce 
transition metals (iron, copper, cobalt) without causing a dramatic pH change 
94,95
, we 
investigated DLPC degradation after freezing in the presence of Na2SO3; these 
experiments were conducted without spiking any exogenous ferrous ion.  Only when 
Na2SO3 was added to the sample containing sucrose did we observe significant DLPC 
degradation (Figure 2.6).  These results are consistent with the suggestion that the 
sucrose used in the formulation possesses trace quantities of Fe
+3





of Na2SO3 undergoes redox with the sucrose-Fe
+3





 species which then undergoes in situ redox reactions to produce the 
more reactive Fe
+2
 ion which ultimately catalyzes DLPC degradation. Although the 
reduction of the iron contaminants in the sucrose by sodium sulfite is more extreme, it is 
somewhat analogous to the reduction of the iron contaminants during lipid peroxidation. 
It is proposed that although the ferric ion contaminants alone did not affect DLPC 
stability, the reduction of the ferric ion contaminants during lipid peroxidation may 
ultimately contribute to DLPC degradation.  Such an effect may be especially relevant to 
formulations incorporating reducing agents that may promote oxidation by metal 
contaminants present in other excipients. 
Lastly, as the ferrozine assay is often utilized to measure iron concentration in 
solutions and biological samples 
100,101
, we used this assay to analyze the sucrose, 
trehalose and hydroxyethyl starch employed in our studies. Our observation that the 
amount of iron detected via this assay was dependent on the amount of HClaq present 
during the ferrozine reaction is consistent with previous studies documenting the 
formation of iron-sugar complexes 
102,103
. These complexes are affected by pH, and acidic 
conditions can cause the dissociation of the iron-sucrose complexes 
104
. Therefore, these 
results are consistent with the suggestion that metal contaminants in sugars are present in 
a less reactive form that can be liberated/activated by other formulation components, and 
ultimately contribute to the observed DLPC degradation.  Moreover, this mechanism is 
relevant to the shelf-life of any pharmaceutical preparation, especially those 





DLPC peroxidation correlated with increased ferrous ion spiked into the 
formulation solution. In addition, our results demonstrate that DLPC degradation 
occurred during the freezing step of lyophilization and was affected by sucrose 
concentration and buffer ionic strength in the freeze concentrate. Recent studies have 
shown that particulate formulations are especially susceptible to damage immediately 
after ice formation due to the high concentration of solutes and relatively high 
temperatures prior to complete solidification 
105
.  In contrast, we report that the high 
solute concentration actually serves to stabilize lipids against metal-catalyzed 
degradation, presumably by disrupting the association with metal contaminants.  Clearly, 
the roles which iron plays are complex, and the observations from this study further 
highlight this complexity. The fact that DLPC peroxidation did not occur unless ferrous 
ion or sodium sulfite was added to the formulation demonstrates that trace metal 
contaminants need to be activated/reduced to serve as effective catalysts for degradation, 
at least during acute lyophilization stress.  While underscoring the importance of using 
high grade pharmaceutical sugars and avoiding contact with metal during manufacturing 
and processing, our results also demonstrate that the common practice of spiking samples 
with iron does not accurately simulate the conditions present in formulations 











Liposomes are bilayer vesicles composed of cationic, anionic and/or neutral 
lipids. Liposomes are frequently used as delivery vehicles; currently, twelve liposomal 
products are marketed to deliver small molecule therapeutics. 
1,106
 The commercially 
available products employing lipid-based delivery vehicles are typically composed of 
saturated, hydrogenated or singly unsaturated lipids; lipids primarily used due to their 
greater intrinsic chemical stability. Regarding liposomal formulations, hydrolysis and 
oxidative processes are the main degradation pathways.  More specifically, the ester 
functionality connecting the fatty acid and glycerol backbone is susceptible to hydrolysis 
resulting in free fatty acids, lysophospholipids and/or glycerophospho compounds. 
107
 It 




In addition to hydrolysis, peroxidation is a serious concern with liposomal drug 
formulations. Peroxidation, a complex free radical mediated process, may be described 
via three distinct steps: i) initiation, ii) propagation, and iii) termination. 
9,10
 Peroxidation 
initiation involves hydrogen atom abstraction (hemolytic cleavage) from the fatty acid to 
produce an initial radical. The number of unsaturated sites in the lipid fatty acid tail 
dictates the ease at which the hydrogen may be abstracted. The carbon-hydrogen bond 
energy progressively decreases from alkyl (101 kcal/mol), to allylic (88 kcal/mol), and 
42 
 
bis-allylic (75-80 kcal/mol). 
11
 These lipid radicals may be resonance stabilized following 
the bond energy trend bis-allylic > allylic > alkyl; hence, the greater intrinsic chemical 
propensity of lipids containing two or more unsaturated sites to undergo greater 
peroxidation. 
9,12
 During the propagation step, the lipid radical may react with oxygen to 
produce a peroxyl radical. 
12
 Once formed, the peroxyl radical may abstract a hydrogen 
atom from another lipid molecule to produce additional lipid radicals and subsequent 
hydroperoxides. 
12
 Additional reactions may also occur such as cyclization, fragmentation 
and rearrangement. 
12
 The final lipid peroxidation step, termination, occurs when radical 
concentrations become very low and results in the coupling of two radicals to form a non-
radical product. 
13
 It has been demonstrated that the physical properties (i.e., permeability 
and fluidity) of liposome bilayers may be altered via peroxidation. 
14-16
 
Many lipid peroxidation studies have utilized aqueous formulations.  More 
specifically, Vossen et al. 
31
 investigated how increasing lipid unsaturation affected the 
ability of copper (II)/H2O2 to catalyze peroxidation. Lipid peroxidation was assessed by 
measuring conjugated diene accumulation; liposomes composed of PLinPC (16:0, 18:2) 
or PLPC (16:0, 18:3) were utilized. As liposomes composed of 16:0/16:1 lipids were 
observed to be insensitive to peroxidation, the formation of conjugated dienes resulting 
from peroxidation were attributed to linoleic acid (18:2) or linolenic acid (18:3). The 
observed peroxidation was much faster in PLPC samples compared to PLinPC samples; 
these data are consistent with the notion that increased peroxidation occurs more readily 
as the degree of unsaturation increases. 
31
 Other studies have also demonstrated a 
correlation between the degree of unsaturation and the susceptibility to oxidative 





Lyophilization is a strategy often employed to improve liposomal formulation 
stability; reactivity being far less pronounced in the solid versus aqueous state.  While 
dehydration would be expected to reduce chemical reactions involving water (i.e., 
hydrolysis), the specific elements that affect the chemical stability of lyophilized 
liposomal formulations (i.e., lipids in the dried state) are not well understood. Some 
studies have been conducted which utilized lyophilized liposomal systems, although 
these studies were primarily concerned with physical phenomena such as liposomal 
aggregation/fusion and the retention of small molecules. 
19-21,110,111
 In an insightful study 
conducted by Mouradian et al. 
44
, sarcoplasmic reticulum (SR) vesicles were prepared 
from isolated lobster tail muscle, lyophilized and stored for forty-nine days.  The 
peroxidation of these SR vesicles was evaluated by monitoring the accumulation of lipid 
hydroperoxides and secondary oxidation products (i.e., aldehydes) using the 
thiobarbituric acid reactive substances (TBARS) assay. Due to the presence of 
polyunsaturated lipids in the sarcoplasmic reticulum membrane, peroxidation was 
expected to be a major degradation pathway. Altering trehalose concentration (0 to 2.0 
grams trehalose/gram membrane) was investigated, and it was concluded that trehalose 
concentration did not affect SR vesicle peroxidation.  However, exposure to light and 
moisture content present in the lyophilized samples dictated by the relative humidity to 
which the samples were exposed during storage (0% and 35%) significantly influenced 
SR vesicle stability. As one would expect, light exposure was conducive to increased 
hydroperoxide accumulation.  Also, secondary oxidation product accumulation 
predominantly occurred in the samples with lower moisture content (exposed to 0% 
relative humidity).  It was suggested that the secondary oxidation products were 
44 
 
chemically less stable, preventing their accumulation and subsequent detection in 
samples with the higher moisture content (exposed to 35% relative humidity). 
 Although liposomes have traditionally been used to deliver small molecules, more 
recent studies have utilized lipid nanoparticles to facilitate the delivery of nucleic acids 
(i.e., DNA, RNA) to the cell interior.  Because polyunsaturated lipids have been shown to 
enhance intracellular delivery, there is increasing interest in developing stable 
formulations containing these types of lipids 
60,62,63
.  The current study assesses the long 
term storage stability of lyophilized liposomal formulations. The effect of liposome 
composition on the chemical stability of lipids in the dried state was evaluated utilizing 
liposomes composed of a triply unsaturated lipid (DLPC, 18:3), a doubly unsaturated 
lipid (DLinPC, 18:2), and a singly unsaturated lipid (DOPC, 18:1). Additionally, 
cholesterol or DOPE was incorporated into the DLPC liposomal formulation to determine 
if the presence of these helper lipids could slow the lipid degradation rate. Lipid 
degradation in lyophilized lipid samples containing trehalose, and stored at various 
temperatures (4°C, room temperature, 37°C, 50°C and 60°C), was evaluated for up to 48 
weeks. The effects of different sugars (trehalose, sucrose, and sorbitol) and the presence 
of chelators, diethylenetriaminepentaacetic acid (DTPA) and deferoxamine (DFO), on 
DLPC degradation were also evaluated. These non-reducing sugars were selected based 
upon their distinctly different glass transition temperatures, thereby allowing us to 
evaluate the role, if any, of glassy dynamics. The effect of other processing parameters 
related to the preparation and lyophilization of samples (e.g., use of degassed buffer, 
rapid freezing) were also investigated. Although this study is primarily concerned with 
the chemical stability of lipids in relation to pharmaceutical applications, other studies 
45 
 
have investigated the stability of lipids in relation to food and beverage products. 
2-8
 In 
order to develop better lipid-based therapeutics for intracellular delivery, further 
investigation of the dried-state storage stability of lyophilized liposomal formulations is 
necessary, especially for polyunsaturated lipids. 
 
Materials and Methods 
 
Materials 
1, 2-Dilinolenoyl-sn-glycero-3-phosphocholine (DLPC; 18:3 (Cis) PC) (>99%, 
Lot # 183PC-12li), 1, 2-dilinoleoyl-sn-glycero-3-phosphocholine (DLinPC; 18:2 (Cis) 
PC)  (>99%, Lot # 182PC-183b), and 1, 2-di-(9Z-octadecenoyl)-sn-glycero-3-
phosphocholine (DOPC 18:1 (Cis) PC) (>99%, Lot # 181PC-257) were purchased from 
Avanti Polar Lipids (Alabaster, AL). Sucrose (Ultrex© ultrapure, Lot # J25H00) was 
acquired from JT Baker (Center Valley, PA). Trehalose (100%, Lot # 28549A) was 
obtained from Ferro Pfanstiehl (Waukegan, IL). Sorbitol (98.9%, Lot # B65414) was 
procured from Calbiochem (La Jolla, CA). Tris [hydroxymethyl] amino-methane, DFO 
(≥ 92.5%, Lot # 032K1210), hydranal water standard 1.0 (Fluka, Lot # SZBB2850V) and 
hydrochloric acid were purchased from Sigma-Aldrich Chemical Company (St. Louis, 
MO). 3-(2-Pyridyl)-5,6-diphenyl-1,2,4-triazine-p,p'-disulfonic acid, disodium salt hydrate 
(ferroZine iron reagent), dimethylformamide (extra dry 99.8%) and propionic acid were 
purchased from Acros Organics (NJ, USA). Chloroform (HPLC grade), water (HPLC 
grade), methanol, (LC/MS grade) acetone (LC/MS grade), freezer boxes, sodium 
hydroxide pellets (Lot # 110388) and Eppendorf tubes (1.5 mL) were procured from 
46 
 
Fisher Scientific (Pittsburgh, PA). High grade nitrogen, helium and argon were obtained 
from Airgas (Radnor, PA). Amber glass vials (5 mL) were purchased from West 
Pharmaceutical Services (Lionville, PA). Solid phase extraction (SPE) tubes 
(Phenomenex Strata X, 1.0 mL) containing sorbent (30 mg; Lot # S300-147) were used 
(Torrance, CA). The aluminum pans and lids were purchased together as part of a kit 
from Perkin Elmer (Norwalk, NJ). Pyridine free vessel solution (Lot # C364746) and 
generator solution (Lot # 0135010) were purchased from Photovolt (Minneapolis, MN).  
 
Sample Preparation 
All lipid stocks were dissolved in chloroform and DLPC, DLinPC and DOPC 
lipid stocks concentrations were 10.0 mg/ml, 25.0 mg/ml and 20.0 mg/ml respectively. 
After transferring the appropriate lipid stock volume, the chloroform was evaporated 
under a slow stream of N2 gas. The lipid was subjected to vacuum (559 Torr; 1.0 hr) to 
remove residual chloroform. The lipid (DLPC, DLinPC or DOPC) was then suspended 
using an aqueous solution containing 2% sugar (trehalose, sucrose or sorbitol) and Tris 
buffer (0.5 mM, pH 7.4) to produce a final lipid concentration of 0.02 mg/ml. The 
rehydrated lipid (DLPC, DLinPC or DOPC) was then sonicated (2.0 min) and gently 
swirled. A 1.0 mL volume was aliquoted into amber glass vials (5 mL) and the final 
sample composition was lipid (0.02 mg/ml) and 2% sugar (sucrose, trehalose or sorbitol). 
After lyophilization and vials sealed, samples were then placed in boxes and stored at 4 ± 
2°C, 22 ± 2°C (room temperature), 37 ± 2°C, 50 ± 2°C, or 60 ± 2°C. When DTPA or 
DFO were added to DLPC samples, DTPA or DFO were dissolved using an aqueous 
solution containing 2% trehalose, 0.5 mM Tris, and the final chelator concentration was 
47 
 
8.9 ppm. The pH of the chelator-containing solution was adjusted to 7.4 using 1.0 µL 
aliquots of 0.1 M NaOH. The resulting solution was used to rehydrate the lipid after 
chloroform removal as previously described. 
 
Lyophilization Protocol 
Sample vials and stoppers were typically washed with 0.1 M HCl water overnight 
and then rinsed three times with high-purity distilled water. Sample vials were placed 
directly on the shelf of a Lyostar 3 (SP Scientific, Gardiner, NY). The SMART 
lyophilization mode was utilized. During the freezing stage, the shelf temperature was 
progressively decreased from room temperature to 5°C, then to -5°C and finally to -40°C. 
The duration of time that the shelf temperature remained at these temperatures was 
related to the number of samples which were being lyophilized as well as the volume and 
composition of the samples. Next, for primary drying, the sample chamber pressure was 
reduced to 57 mTorr. After primary drying was complete (as indicated by a decrease in 
the pressure as measured by the pirani pressure gauge indicating the end of bulk water 
sublimation), the shelf temperature was increased at a rate of 0.1 °C/min, and secondary 
drying was conducted at 30°C (1800 min). Sample temperatures were monitored by 
inserting a thermocouple into a representative sample prior to starting the lyophilization 
cycle. After sample lyophilization was completed, the vials were stoppered while the 
chamber remained under vacuum. The samples comparing the effect of the degree of 
lipid unsaturation, which contained DLPC, DLinPC and DOPC, and the effect of 
different sugars were lyophilized in the same run. The samples containing sorbitol or 
48 
 
sucrose collapsed during lyophilization and storage, respectively, whereas the structure of 
the trehalose samples was maintained throughout the duration of the experiments. 
 
HPLC-UV Analysis 
The DLPC remaining in stored samples were measured utilizing the HPLC/UV as 
previously described. 
45
 To measure DLinPC and DOPC, the percent of methanol in the 
mobile phase was increased from 95% to 97% (19:1 methanol:water to 19.4:1 
methanol:water). The duration of the method varied from 20 to 25 minutes depending on 
which lipid was being analyzed.  For all analyses, a Shimadzu analytical HPLC system 
(LC-20AB, DGU-20A, CTO-20A, Sil-20A HT) equipped with SPD-20A UV-VIS 
detector was utilized (Shimadzu Scientific Instruments, Inc.; Columbia, MD). A zorbax 
extended-C18 50 x 4.6 mm (5 micron) column in combination with a guard column was 
used (Aligent, Santa Clara, CA). The flow-rate was 0.4 mL/min and the column 
temperature was maintained at 40°C. An isocratic method was used, and UV detection 
was monitored at 205 nm. For samples and standards (DLPC, DLinPC and DOPC), 10 
μL sample volumes were injected. 
 
Solid Phase Extraction Procedure 
DLPC degradation product analysis was performed via GC/MS but required the 
removal of the sugar component; therefore we utilized a solid phase extraction (SPE) 
procedure. The SPE procedure was identical to that previously described by Payton et al  
45
. An internal standard solution, propionic acid (final concentration 10.0 μg/ml) diluted 




To monitor DLPC degradation products, a Shimadzu GC/MS-QP2010 Plus 
(Shimadzu Scientific Instruments, Inc.; Columbia, MD) gas chromatograph mass 
spectrometer was utilized. A Phenomenex ZB-FFAP analytical column (30m x 0.25mm x 
0.25 mm) was used in tandem with a 5 meter guard column (Phenomenex, Torrance, 
CA). The settings were as follows: column temperature was initially set at 50°C with an 
injector temperature of 250°C; the oven temperature was held at 50°C for 6.0 min, 
ramped at 8 °C/min to 200°C and held for 10.0 min and then the temperature was 
increased at 8 °C/min to 230°C. The interface temperature was 230°C and the ion source 
temperature was 210°C. The column flow rate was 1.0 mL/min and helium was used as 
the carrier gas. The total flow was 14.1 mL/min and the purge flow was 3.0 mL/min. The 
pressure was 539 torr. The splitless mode was used and the sampling time was 1.0 min 
after which the split mode was utilized (split ratio of 10). The detector delay was set to 
5.0 min. The scanning mode was utilized and the event time was set to 0.5 sec from 5.0 
min to 11.5 min (scan speed 1428) and 0.2 from 13.0 min to 47.5 min (scan speed 5000). 
The injection volume was 1.0 μL. Peaks corresponding to propanoic acid, the internal 
standard, and the main product detected in lyophilized DLPC samples were monitored.  
 
Moisture Content Analysis 
The moisture content of lyophilized samples shown in Table I was determined 
using a DL37 coulometric moisture analyzer (Mettler Toledo, Columbus, OH) using 
pyridine free vessel solutions (Photovolt Instruments, Inc., St. Louis Park, MN). The 
samples were prepared in a glove box purged with dry nitrogen to avoid absorption of 
50 
 
ambient air moisture. Anhydrous dimethylformamide was used to dissolve lyophilized 
samples. Samples were extracted from the lyophilization vials through the stopper, and 
the moisture content was subsequently analyzed as previously described. 
89,112
 Sample 
moisture content was analyzed after lyophilization and after storage at the various storage 
temperatures utilized in this study.  
 
Differential Scanning Calorimetry 
Samples containing trehalose, sucrose or sorbitol were analyzed (thermal 
analysis) using a Perkin-Elmer Diamond DSC (Norwalk, CT). All samples were prepared 
in a glove box purged with dry nitrogen to prevent moisture absorption from the ambient 
air. The lyophilized cake (≈ 2 mg of powder) was removed from the lyophilization vial 
and the sample was placed in an aluminum pan and sealed. Trehalose samples were 
heated (from 25°C to 150°C) at 100 °C/min, held for 5.0 min, cooled to 25°C, and 
reheated again to 150°C. Sucrose samples were heated (from 0°C to 100°C) at 100 
°C/min, held for 5.0 min, then cooled to 0°C, and reheated again to 100°C. Sorbitol 
samples were heated (from -40°C to 50°C) at 20 °C/min, held for 5.0 min, then cooled to 
-40°C, and reheated again to 50°C. The second scan was used to measure the glass 
transition temperature (Tg). The reported Tg values (Table I) refer to either the onset 








Ferrozine and ascorbic acid were dissolved in 1.0 M HCl to afford final 
concentrations of 20 mM and 200 mM, respectively. The ascorbic acid/ferrozine solution 
(20 µl) was added to each sample (340 µl), mixed, and heated (60°C, 20 min). After 
cooling the reagent/sample to room temperature (12 h), the absorbance was measured at 
562 nm. Ferric citrate standards were used to generate a standard curve covering a 
concentration range of 0–800 ppb (R
2
 = 0.94). 
 
Electron Spectroscopy for Chemical Analysis and Specific Surface Area 
Previously published techniques were utilized to measure the lipid molecules on 
the surface of lyophilized trehalose samples; electron spectroscopy for chemical analysis 
(ESCA) and the specific surface area of lyophilized trehalose samples via Branauer, 
Emmett and Teller (BET) krypton adsorption. 
113
 The mass of the lipid molecules on the 




Dynamic Light Scattering to Measure Hydrodynamic Diameter 
A liposome suspension containing 0.02 µg/mL DLPC and 2% trehalose in Tris 
buffer was prepared as described above. An aliquot (200 µL) was transferred to a quartz 
cuvette and the size of DLPC liposomes was measured using dynamic light scattering 
(DLS) with a Zetasizer Nano- ZS (Malvern, UK). The reported diameter of DLPC 
liposomes (504 nm) was based on the size distribution by volume and the % volume of 






Effect of Liposome Composition and Degradation as a Function of Temperature 
Significant DLPC degradation in samples occurred at 37°C, 50°C, and 60°C 
(Figure 3.1a) while significant degradation of DLinPC in samples was only observed at 
50 °C and 60 °C (Figure 3.1b). Appreciable DLPC and DLinPC degradation did not 
occur at the lower storage temperatures, 4°C and 22°C (room temperature). DOPC 
samples were found to be stable at all storage temperatures over 48 weeks (data not 
shown). From these data, it is clear that the degree of lipid unsaturation influenced the 
degradation rate with increased degradation observed with increasing degree of lipid 
unsaturation (compare Figures 3.1a+b). As expected, degradation rate was faster as the 
storage temperature was increased (Figure 3.1a+b).  The initial degradation rate was 
estimated by plotting the natural log of DLPC µgrams remaining at the first three time 
points. The pseudo first order rate constant, kobs, and the half-life (T1/2) were extrapolated 
from this plot (Figure 3.1c) which allowed for the construction of an Arrhenius plot 
(Figure 1d) to afford an estimation of the activation energy, Ea, at 21.6 kcal/mol.  This 
value is comparable to other Ea values which have been reported previously for the 




Analysis of DLPC Degradation Products  
DLPC degradation products were measured via GC/MS. Although a GC/MS 
method for analyzing DLPC degradation products was developed for a prior study 
45
, the 




Figure 3.1: Lipid degradation during storage. A) DLPC loss as measured by HPLC in 
samples stored at 60°C, 50°C, and 37°C. B) DLinPC loss as measured by HPLC in 
samples stored at 60°C, 50°C and 37°C. C) Initial DLPC degradation rate (time points 0, 
1 and 2) for samples stored at 60°C, 50°C, and 37°C. Rate constants (kobs) and the half-
life (t1/2) were determined from the linear regression. For the samples stored at 60°C, 
50°C, and 37°C, the R
2
 values for the linear regression trend lines are 0.9931, 0.9431 and 
0.9762 respectively.  D) Arrhenius graph plotted using the extrapolated rate constants 
versus 1/T (K
-1 
x 1000).The values represent the mean ± 1 SEM of triplicate 
determinations; errors are within the symbol size. 
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detected in unspiked samples. The DLPC samples in the current study did contain trace 
levels of iron due to the contaminants inherent in the sugars, but it was observed that the 
degradation products were different. More specifically, the accumulation of one distinct 
product, referred herein as Product B, was observed. A representative chromatogram 
illustrating the internal standard peak (propionic acid; tr = 15.5 min) and Product B (tr = 
23.75 min; inset) is presented in Figure 3.2a. The accumulation of Product B was 
observed and the relative amount of Product B increased as DLPC degradation occurred 
over time (Figure 3.2 b+c). The rate of Product B accumulation was dependent upon the 
storage temperature, and Product B accumulation was most rapid in DLPC samples 
stored at 50°C. (Figure 3.2c) A relatively slower accumulation of Product B was 
observed for samples stored at 37°C (Figure 3.2b).  Product B was not detected in 
samples stored at 60°C, presumably due to instability at elevated temperature. 
 
Effect of the Inclusion of Helper Lipids 
 Cholesterol and DOPE, often referred to as helper lipids, are frequently included 
in liposomal formulations to improve the intracellular delivery of the cargo encapsulated 
or associated with the liposome. 
116
 It is well known that cellular uptake of liposomes 
occurs via endocytosis resulting in entrapment within an endosome. 
117
 Endosomal 
escape is essential to avoid degradation of the liposome and the encapsulated cargo in the  
55 
 











































































































Figure 3.2: Product B accumulation in DPLC samples during storage. A) Representative 
gas chromatogram. Internal standard (propanoic acid) tR=15.5 minutes. Inset shows a 
chromatogram which has been rescaled to show the peak corresponding to the measured 
product (Product B) tR= 23.75. B) Loss of DLPC (closed circles) and the accumulation of 
Product B (open circles) in samples stored at 37°C. C) Loss of DLPC (closed circles) and 
the accumulation of Product B (open circles) in samples stored at 50°C. The values 




lysosome, and helper lipids are capable of promoting endosomal escape. 
116
 To assess the 
potential effect of helper lipids on storage stability, DOPE and cholesterol were each 
incorporated separately into the DLPC-trehalose formulation and stored at 60°C.  Besides 
a DLPC-only formulation, two different helper lipid mole ratios were tested: 1:1 
(DLPC:helper lipid) and 9:1 (DLPC:helper lipid). DLPC degradation was not mitigated 
by the inclusion of DOPE or cholesterol, and the mole percent of each helper lipid also 
did not alter the observed rate or extent of DLPC degradation (Figure 3.3a+b). 
 
Effect of the Lyoprotectant (Trehalose, Sucrose or Sorbitol) 
DLPC samples formulated with trehalose, sucrose or sorbitol were lyophilized 
and stored at 60°C. It was hypothesized that the rate of degradation for the DLPC-sugar 
samples would correlate with the glass transition temperature of the sugars, and that the 
samples lyophilized in trehalose (Tg = 122.0 ± 0.1°C), sucrose (Tg = 60.6 ± 0.03°C) and 
sorbitol (Tg = -5.4 ± 0.1°C) (Table I) would exhibit relatively slow, intermediate and fast 
degradation rates, respectively. 
54,118
  However, the DLPC-trehalose samples exhibited a 
slightly faster degradation rate relative to the DLPC-sucrose and DLPC-sorbitol samples 
(Figure 3.4). The rates of DLPC degradation for the samples formulated in sucrose and 
sorbitol were comparable.  It has been shown that the chemical degradation of molecules 
in the dried state (e.g. lipids, proteins) may not correlate with Tg 
119-122
 especially when 
small reactants, such as oxygen or reactive oxygen species, are able to diffuse through the 
amorphous matrix. 123-125 
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Figure 3.3: Degradation of DLPC and DLPC-helper lipid formulations as measured by 
HPLC. A) Degradation of DLPC and DLPC:DOPE formulations after 6 weeks of storage 
at 60°C. The DOPE formulations contain 50% DOPE (1:1), or 10% DOPE (9:1). B) 
Degradation of DLPC and DLPC:cholesterol formulations after 6 weeks of storage at 
60°C. The cholesterol formulations contain 50% cholesterol (1:1), or 10% cholesterol 





























Figure 3.4: Degradation of DLPC samples formulated with different sugar excipients as 
measured by HPLC. Samples were stored at 60°C for up to 135 days (≈ 19 weeks). 
Closed circles – trehalose; closed squares – sucrose; and closed triangles- sorbitol. The 
values represent the mean ± 1 SEM of triplicate determinations; errors are within the 
symbol size. 
 













Trehalose  0.32 ± 0.07 122.0 ± 0.1 0.67 ± 0.05
 
 114.5 ± 0.9 
Sucrose 0.31 ± 0.11 60.6 ± 0.03 0.36 ± 0.10 59.2d 
Sorbitol 0.34 ± 0.08 -5.4 ± 0.1 0.48 ± 0.15 -5.8 ± 0.2 
 
 
Table 3.1: Moisture content and glass transition temperature for samples stored for 48 
weeks. 
a
 Values represent the mean ± SEM n=4 or 5. Moisture content expressed as 
weight percent. 
b 
Moisture content and Tg values for samples stored at 60°C. Only 
trehalose samples were stored at lower temperature and the moisture content of trehalose 
samples stored at lower temperatures was comparable. (data not shown)
c 
Tg values 




Effect of Chelators 
It is known that pharmaceutical grade sugars, such as those utilized in this study 
as lyo-protectants, inherently contain trace metal contaminants. 
43,45
  Specifically, iron is 
a common contaminant known to be present in pharmaceutical grade sugars; the 
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lyophilized trehalose samples in the current study contained approximately 1.78 ± 0.01 
ppm iron (n =3, average ± SEM data not shown).  To assess the influence of the iron 
contaminants on the stability of lipids in the dried state, DTPA and DFO were added to 
DLPC samples prior to lyophilization and storage at 60°C (4 weeks). The addition of 
DTPA or DFO to DLPC samples formulated in trehalose significantly (p < 0.0001) 
decreased the observed DLPC degradation that occurred during storage (Figure 3.5). 






















Figure 3.5: Effect of iron contaminant chelation on DLPC stability. 
Degradation of DLPC with and without DTPA or deferoxamine as measured by HPLC in 
samples lyophilized and stored at 60°C for 4 weeks. Chelator concentration was 8.9 ppm 
which is 5 times greater than the concentration of the iron contaminants (1.78 ppm). 
White bars - after lyophilization, no storage. Black bars - after 4 weeks of storage at 
60°C. The values represent the mean ± 1 SEM of triplicate determinations. Degradation 
of stored DLPC samples containing chelator compared to stored DLPC samples 
containing no chelator. *, p < 0.0001 
 
 
Effects of Freezing Method and Degassing  
The effects of freezing method and buffer degassing on the storage stability were 
evaluated in samples formulated with trehalose. Because slow versus fast freezing rates 
have been shown to influence the gas content (O2 and N2) of aqueous formulations 
126
,  




samples were frozen utilizing two different protocols: plunging vials directly into liquid 
nitrogen or placing on the lyophilizer shelf which was subsequently cooled to -40°C. The 
observed DLPC degradation was not dramatically altered by the freezing method and 
76.6 ± 0.9 % and 73.2 ± 0.9 % (average ± SEM) of the initial DLPC remained in samples 
frozen in liquid nitrogen and on the lyophilizer shelf, respectively, after 4 weeks of 
storage at 60°C (Figure 3.6). Because we speculated that oxygen may be playing an 
important role in the observed DLPC degradation, degradation was assessed in samples 
prepared with buffer degassed via nitrogen bubbling. Compared to samples prepared with 
the standard buffer, DLPC degradation was comparable and no significant differences 
were observed.  More specifically, samples prepared with standard and degassed Tris 
buffer and stored at 60°C for 4 weeks, 73.2 ± 0.9 % and 73.0 ± 2.2 % (average ± SEM) 
DLPC remained, respectively (Figure 3.6).  
























Figure 3.6: Effect of processing conditions on the degradation of lyophilized DLPC 
samples during storage. Samples were stored at 60°C for 4 weeks. Degradation of DLPC 
in samples which were made with standard (i.e., not degassed) buffer and frozen slowly 
in the lyophilizer (black bar) or frozen rapidly by plunging vials into liquid nitrogen 
(hashed bar).  Another set of samples were also frozen slowly in buffer degassed by 






Lyophilized liposomal formulations have been utilized successfully in marketed 




; however, these 
formulations utilize saturated or singly unsaturated lipids. 
1
 The use of multiply 
unsaturated lipids in lipid-based commercial products has been avoided due in part to 
their greater susceptibility to oxidative degradation despite their ability to improve 
intracellular delivery by enhancing endosomal escape. 
60
 Although many studies have 
evaluated the degradation of aqueous liposomal formulations 
29,30,37,91,127,128
, few studies 
have investigated the stability of liposomal formulations in the dry state. The limited 
studies examining liposomal formulation stability in the dried state have focused on 
physical phenomena (aggregation/fusion, retention of small molecules etc.), or were 
limited in terms of duration or the use of non-specific techniques for product detection 
(e.g., thiobarbituric acid reactive substances assay). 
19-21,44,110,111
 The goal of the current 
study was to characterize the long term storage stability of lyophilized liposomal 
formulations and to evaluate the effect of liposome composition, formulation strategies, 
and processing parameters on the degradation of unsaturated lipids in the dried state.  
Lipid loss resulting from degradation during storage was monitored using a 
previously developed method 
45
 but slightly altered to allow for the analysis of DLinPC, 
DOPC and DLPC. Significant degradation was observed for DLPC and DLinPC samples, 
whereas degradation of DOPC samples was not evident even after 336 days (48 weeks) 
of storage at 60°C. For the DLPC samples stored in trehalose at 37°C and 50°C, Product 
B accumulation was measured via GC/MS (Figure 3.2b+c). As DLPC degraded, a 
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corresponding increase in Product B was observed. DLPC samples stored at 50°C 
displayed the accumulation of Product B, which continued even after the rate of DLPC 
loss decreased (e.g., after 75 days in Figure 3.2c); these observations support that notion 
that DLPC does not directly degrade to Product B and that intermediate species (e.g., 
lipid hydroperoxides) are most likely involved in Product B formation. The degradation 
of DLPC samples occurred over a wider range of temperatures and at a faster rate relative 
to DLinPC samples (Figure 3.1a+b). These results suggest that increased liposomal 
degradation in the dried state was dependent upon the degree of lipid unsaturation, and 
consistent with previous studies conducted using aqueous liposomal formulations; studies 
that concluded that multiply unsaturated lipids were particularly susceptible to oxidative 
degradation due the relative ease with which bis-allylic hydrogens may be abstracted. 
9,11
 
In addition to examining the effect of increasing unsaturation on the stability of 
lyophilized samples, our data show that the stability of DLPC was not improved by co-
formulation with helper lipids (cholesterol or DOPE). Previous studies with hydrated 
formulations have reported inconsistent effects of cholesterol on the oxidative 
degradation of liposomal formulation, and results appear to depend on the composition of 
the liposomal formulation and the temperature at which the study was conducted. 
36
 For 
example, a study by Mowri et al. 
30
 reported a progressive decrease in oxidative 
degradation with increased cholesterol. It was proposed that the effect of cholesterol on 
the fluidity of the lipid bilayer caused the reduced peroxidation which was observed. 
Similarly, Samuni and Barenholz 
37
 examined the stability of egg PC (EPC) liposomes 
formulated with or without cholesterol and stored at room temperature for up to 10 
months. Decreased peroxidation was observed in EPC:cholesterol (10:1) liposomes 
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relative to pure EPC liposomes. The decreased oxidative degradation of EPC-cholesterol 
liposomes was attributed to a more tightly packed bilayer, hindrance of the free radical 
mediated propagation reactions, and decreased bilayer hydration. However, another study 
examining the effect of cholesterol on the stability of EPC liposomes reached somewhat 
different conclusions.
38
  In this latter study, the hydrophilic azo initiator, 2,2'-azobis-2-
methyl-propanimidamide, dihydrochloride (AAPH), was utilized and the cholesterol 
content was varied from 0% to 45% (mol %). Overall the presence of cholesterol did not 
alter the oxidation of egg PC liposomes except for the formulation which contained 10% 
cholesterol. Surprisingly, the oxidation detected in this formulation was greater than any 
of the formulations containing higher cholesterol contents. 
38
 The authors suggested that 
increased peroxidation at 10 mol% cholesterol could be attributed to the coexistence of 
liquid disordered and ordered (LD and LO) phases, but it is unclear why such phases 
would not exist at the higher cholesterol concentrations that did not exhibit increased 
peroxidation.  Although the studies mentioned above are clearly conflicted regarding to 
the ability of cholesterol to affect peroxidation in aqueous formulations, our results 
strongly suggest that cholesterol does not affect DLPC degradation in the dried state.  
Curiously, DLPC formulated in trehalose and stored at 50°C and 60°C, as well as 
the DLinPC samples stored at 60°C, lipid levels remained constant after an initial phase 
of steady degradation (Figure 3.1a). The underlying cause of the decreased degradation 
rate (i.e., the observed plain) was considered from a variety of perspectives. It was 
hypothesized that the decrease in the degradation rate may be related to lipid molecules 
on the surface of the trehalose cakes degrading more rapidly due to exposure to gases 
(e.g., O2) in the vial headspace as compared to lipid molecules that are located in the 
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interior of the cake. To evaluate this potential explanation, the mass of the lipid 
molecules on the surface of lyophilized trehalose cake was assessed, and it was 
determined that approximately 12% of the lipid molecules were located on the surface. 
Since approximately 75% (Figure 3.1a) of the lipid molecules degraded before the lipid 
concentrations appeared to level off (i.e., the plain), we concluded that surface exposure 
does not account for the marked decrease in degradation rate. 
Alternatively, it was speculated that the accumulation of lipid hydroperoxides in 
the chloroform lipid stock might also be influencing the observed degradation profile. For 
example, each time the lipid stock was opened it was briefly exposed to ambient 
atmosphere potentially resulting in the introduction oxygen and the initiation of lipid 
hydroperoxide formation. Considering the iron contaminants known to be present in the 
sugars of these formulations, the hydroperoxides could potentially decompose as a result 
of reaction with iron forming peroxyl radicals. 
27,129,130
 To test if the age/handling of the 
lipid stock affected the amount of lipid remaining when the plain occurred, a freshly 
opened DLPC lipid stock as well as older lipid stocks opened 7 and 16 months earlier 
were used to prepare samples. After lyophilization, the DLPC-trehalose samples were 
stored at 60°C for 42 days (6 weeks); the duration of storage was chosen because in 
previous experiments it was observed that the decrease degradation rate (i.e., plain) 
occurred after 29 days (time point 3, Figure 3.1a) . Although we did observe some 
differences in the DLPC remaining after storage, they did not correlate with the age of the 
lipid stock.  
Another possible explanation for the plain is the depletion of a molecule (i.e., 
reactant) present in the sample vial which could be participating in the degradation 
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reaction. The involvement of oxygen as a reactant is suspected because aldehyde 
products, which are characteristic products of lipid oxidation, were detected via the 
TBARS assay in DLPC samples stored at 37°C (data not shown). Oxygen could 
potentially originate from several different sources including gaseous oxygen in the 
headspace of the sample vials, leaking of the ambient atmosphere into the vials which 
were stoppered under vacuum, and dissolved oxygen present in the aqueous sample prior 
to lyophilization. However, since the removal of oxygen from the aqueous sample prior 
to lyophilization did not affect stability (Figure 3.6), and the variability between the 
samples was low (leaking would be expected to cause high variability among vials), we 
feel that it is unlikely that oxygen originated from these sources. Gaseous oxygen in the 
headspace of the vials is most likely the result of the residual atmospheric gases 
remaining after the pressure was decreased from atmospheric pressure to 57 mTorr.  Even 
at the low pressures used during lyophilization (e.g. 57 mTorr), we calculate that 
approximately 5.1 nmoles of oxygen is present in the vial. Relative to the 25.7 nmoles of 
DLPC, the amount of gaseous oxygen may be sufficient to participate as a reactant in the 
DLPC degradation reactions; furthermore, small molecules such as oxygen are capable of 
diffusing readily through the lyophilized cake (e.g., amorphous sugar matrix). 
125,131
    
However, we believe that the most likely explanation for the observed plain 
involves the relative number of iron atoms (i.e., iron contaminants) present within and 
outside of the liposome, and the recruitment and subsequent interaction of these iron 
atoms (and their oxidation state) with the lipids while the sample was in the liquid state 
prior to lyophilization. During preparation, the liposomes were rehydrated with a Tris 
buffer solution containing trehalose, so both the inner and outer leaflet of the liposome 
66 
 
would be exposed to the sugar excipient (e.g., trehalose) and also the iron contaminants 
in the sugar. Based on the average approximate size of the DLPC liposomes (504 nm), 
the interior liposome volume is quite small (i.e., 6.3  10
-14 
mL) relative to the aqueous 
volume outside of the liposome (i.e., 1.0 mL). Accordingly, approximately 24 iron atoms 
are present within the liposome giving a 1:4516 iron-to-lipid mole ratio. In contrast, the 
lipids in the outer liposome leaflets are exposed to significantly higher amounts of iron; a 
1:40 iron-to-lipid mole ratio. This calculation suggests that the inner leaflet of the 
liposome would be less susceptible to iron-catalyzed degradation due to the lower iron-
to-lipid ratio within the liposome; this could potentially explain the leveling-off of lipid 
degradation (plain) observed during storage.  
 Adding chelating agents (to bind/inactivate metals) or protectants with high Tg 
values are useful formulation strategies used to improve lyophilized formulation stability. 
Consequently, we examined the influence of adding small quantities of additives and 
their ability to alter DLPC degradation in the dried (lyophilized) state. Based upon 
ferrozine assay measurements, the level of iron contaminant in the dried trehalose was 
1.78 ppm; iron atoms are predominantly in the ferric state due the exposure of the 
trehalose (containing the iron contaminants) to the ambient atmosphere during storage. 
45
 
Addition of either DFO or DTPA (8.9 ppm) had a marked effect on DLPC stability after 
storing at 60°C for 28 days (Figure 3.4). The decreased DLPC degradation in samples 
containing DTPA or DFO supports the notion that iron (and potentially traces of other 
metals, e.g., Cu
+2
) deleteriously impacts the overall lipid stability in the dried state. 
Although the exact mechanism(s) by which iron catalyzes DLPC degradation was not 
fully elucidated in the current study, this data clearly illustrates that a method that 
67 
 
circumvents iron exposure results in a more stable lipid formulation.  The reaction of 
oxygen with lipid molecules leading to oxidative degradation is supported by the fact that 
iron is well-known to catalyze the reaction between oxygen and lipid molecules 
25,27
, and 
the observation that the lipid degradation increases as the degree of unsaturation 
increases. It is important to note that DTPA and DFO are particularly effective iron 
chelators because they occupy all of the iron coordination sites. 
132,133
 Thus, the increased 
DLPC stability in the presence of DTPA or DFO most likely results from iron being 
unable to catalyze the degradation reaction. Lastly, we also examined if glassy state 
dynamics were playing a role in determining degradation rate of the lyophilized DLPC 
formulations; we formulated with three different sugars with distinctly different Tg 
values. DLPC degradation rate in the different sugar formulations did not correlate with 
state (glass or rubber) of the sugar amorphous matrix. Considering that the diffusion of 
lipids would likely be affected by the physical state of the matrix, this result suggests that 
the translational mobility of the lipid molecules was not dictating the rate of degradation, 
but it does not rule out a role for small molecules (e.g., O2) that are less affected by the 




This study examined the effect of liposome composition as well as a variety of 
formulation strategies and processing parameters on the long term stability of unsaturated 
lipids in the dried state. The degradation of lyophilized liposome samples increased as the 
degree of lipid unsaturation increased. The rate of lipid degradation occurred at a greater 
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rate at higher storage temperatures, but the state of the lyophilized samples (glass or 
rubber) did not correlate with observed degradation rates.  The incorporation of helper 
lipids (cholesterol and DOPE) into the liposome formulation did not improve the 
chemical stability of the triply unsaturated lipid, DLPC. The addition of chelators, DTPA 
and DFO, significantly improved the stability of DLPC, indicating that trace levels of 
metal contaminants contribute to the observed degradation during storage.  We feel that 
this is a significant finding considering that our earlier work concluded that trace levels of 
iron contaminants do not facilitate degradation during acute lyophilization unless 
reducing agents are present in the formulation.  In this context, it is possible that even 
fairly inert molecules (e.g., sugars) may be capable of reducing iron during prolonged 
storage, thereby converting iron to a more reactive form.  This suggestion is consistent 
with previous studies in our laboratory wherein lyophilized sugar-only controls generate 
reactive species during prolonged storage. 
89
 The reduction of the iron contaminants is 
also significant as this would alter the ferric-to-ferrous ratio. The presence of both ferrous 
and ferric ions may play a role as it has been demonstrated that the ratio of the ferric-to-
ferrous ions influences the rate of lipid peroxidation initiation, and that a ratio of at least 
1:1 can increase the rate of free radical initiation. 
96,134
  The conversion of iron to the 
more reactive form (Fe
2+




 ratio should not be 
overlooked and are important factors that can impact the stability of lyophilized 
formulations. Although a specific mechanism of lipid degradation in the dry state was not 
elucidated, the results from this study may be useful for developing stable formulations of 









This thesis has focused on characterizing the degradation of unsaturated lipid 
formulations during the lyophilization process as well as during storage.  The interest in 
using unsaturated lipids in pharmaceutical formulations has gained increased significance 
due to their ability to facilitate intracellular delivery.  Lipid degradation was measured via 
methods developed as part of my thesis work.  More specifically, reverse phase HPLC 
was utilized to quantitatively measure the lipid loss. Initially, it was envisioned that the 
thiobarbituric acid reactive substances assay (TBARS), which measures aldehydes such 
as malondialdehyde, would be used to assess the accumulation of degradation products. 
However, it was determined that the levels of aldehydes produced during degradation 
decreased during the storage of lyophilized samples, presumably due to either the 
volatilization of the low molecular weight products at elevated storage temperatures 
and/or the further degradation of the aldehyde products. Because of this limitation, as 
well as the non-specific nature of the TBARS assay, a GC/MS method was developed to 
measure the accumulation of lipid degradation products.  The experimental system used 
throughout this work was composed of either a singly, doubly, or triply unsaturated 




In chapter II, the degradation of a triply unsaturated lipid (DLPC), during 
lyophilization was assessed. DLPC was formulated with sucrose and these samples were 
spiked with ferrous ions to mimic the iron contaminants known to be present in 
pharmaceutical-grade sugars. It was demonstrated that DLPC degradation increased with 
increasing ferrous ion concentration, and that DLPC degradation correlated with the 
accumulation of a degradation product (Product A) as measured by GC/MS. It was also 
determined that DLPC degradation occurred during the freezing step of lyophilization; 
specifically during the initial portion of the freezing process when ice crystal formation 
and freeze concentration were occurring. The sucrose concentration, which dictates the 
volume of the non-ice fraction, and the buffer ionic strength significantly, affected the 
degradation that occurred during the freezing step. It was observed that lower sucrose 
concentrations which are associated with smaller volumes of the non-ice fraction and 
higher ionic strength in the freeze concentrate mitigated DLPC degradation. The 
decreased DLPC degradation in samples with a greater ionic strength suggested that the 
increased concentration of ions may interfere with the interaction between the cationic 
ferrous ions and the anionic phosphate group of the lipid molecules. The significance of 
the oxidation state of the iron in DLPC samples was also examined. It was hypothesized 
that the iron contaminants present in the sucrose were in the ferric (Fe
3+
) form due to 
exposure to the ambient atmosphere during processing, packaging and storage. To 
evaluate the influence of the oxidation state of iron on DLPC stability, sodium sulfite 
(Na2SO3) was added to DLPC samples which did not contain any exogenous iron. 
Na2SO3 is known to participate in redox reactions with Fe
3+ 
ions, resulting in the 











Only in samples containing sucrose (the source of the ferric ion contaminants) and 
Na2SO3 was significant degradation observed after freezing. These results are consistent 
with the suggestion that Na2SO3 undergoes redox with the sucrose–Fe
+3
 complex to 
produce Fe
+2
 and/or displaces the Fe
+3
 species which then undergoes in situ redox 
reactions to produce the more reactive Fe
+2
 ion which ultimately catalyzes DLPC 
degradation. Although the reduction of the iron contaminants in the sucrose by sodium 
sulfite is more extreme, it is somewhat analogous to the reduction of the iron 
contaminants during lipid peroxidation. It is proposed that although the ferric ion 
contaminants alone did not affect DLPC stability, the reduction of the ferric ion 
contaminants during lipid peroxidation may ultimately contribute to DLPC degradation. 
Although we attempted to mimic the iron contaminants by spiking DLPC with ferrous 
ion, the nature of iron ions in solution is complex due to factors such as the oxidation 
state, formation of iron-ligand complexes, and the variability of iron reactivity depending 
on these and other factors. The Na2SO3 experiment highlights this complexity, and 
illustrates the potential of trace metal contaminants to catalyze degradation.  
In chapter III, the long term stability of lyophilized liposomal formulations was 
assessed. PC lipids with increasing levels of unsaturation were utilized in this study to 
evaluate the effect of liposome composition on stability. The dried-state storage stability 
of a singly unsaturated lipid (DOPC), a doubly unsaturated lipid (DLinPC), and a triply 
unsaturated lipid (DLPC) formulated in trehalose was assessed. The degree of 
unsaturation correlated with the rate of degradation such that the more highly unsaturated 
lipid, DLPC, degraded faster relative to DLinPC and DOPC. Because unsaturated lipids 
used for intracellular delivery are typically formulated with helper lipids (e.g., 
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cholesterol, DOPE), the effect of helper lipids on stability was investigated.  Our results 
clearly demonstrate that the degradation of DLPC formulations was not affected by 
incorporating DOPE or cholesterol, indicating that stability of the polyunsaturated lipids 
in such formulations is a significant concern for commercial development.   
This study demonstrated that appreciable degradation only occurred at elevated 
storage temperatures (e.g., 37°C or greater for DLPC samples and 50°C and greater for 
DLinPC samples). For the DLPC samples which were stored at room temperature and 
4°C,  97.5% ± 1.2% and 101.9% ±0.74% was remaining and for the DLinPC samples 
which were stored at 37°C, room temperature and 4°C, 98.5% ± 0.43%, 100.0% ± 1.0% 
and 101.9% ±0.74% was remaining. The observed degradation of DLPC and DLinPC 
was which negligible at the lower storage temperature (e.g., 4°C) suggests that it may be 
possible to incorporate polyunsaturated lipids into commercial liposome formulations. 
The experiment which investigated the effect of incorporating chelators into DLPC 
samples demonstrated that DLPC stability was greatly improved in the samples with 
contained DTPA or DFO. More specifically, the degradation of the least stable lipid, 
DLPC, was significantly decreased when the samples were stored at 60°C such that 
73.2% ±0.89%, 99.3% ± 0.64% and 94.6% ± 2.0% was remaining in the samples which 
contained no chelator, DTPA and DFO respectively. This result suggests that iron 
contaminants, which are in the ferric state 
45
, are playing a role in the degradation of the 
lipid molecules in the dried state. The improved stability that was observed in the 
samples containing a chelator, especially DTPA, combined with storage at room 
temperature or 4°C could improve the stability sufficiently for the commercial 
development of liposomal products containing polyunsaturated lipids to be worthwhile.  
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The stability of DLPC when formulated with trehalose (Tg = 122.0 ± 0.1°C), sucrose (Tg 
= 60.6 ± 0.03°C) or sorbitol (Tg = -5.4 ± 0.1°C) was assessed for samples stored at 60°C. 
The chemical stability of DLPC formulations did not correlate with the mobility of 
amorphous sugar matrix; DLPC degradation was slightly faster in the trehalose 
containing samples and the sucrose and sorbitol containing samples exhibited nearly 
equal rates of DLPC degradation. Consistent with previous studies, the chemical 
degradation of the lyophilized formulations did not correlate with the Tg 
119-122
 however, 
the importance of the state of the sugar matrix (i.e., glass or rubber) and the 
corresponding mobility within the glassy matrix can affect the physical stability (e.g., 
aggregation) of lyophilized liposomal formulations. Liposomal aggregation has been 







My thesis research has aimed to characterize the degradation of lipids during the 
lyophilization process and also during storage. Very few studies have examined the long 
term chemical stability of lyophilized liposomal formulations and further work is 
necessary to better understand the mechanism causing lipid degradation in the dried state. 
One approach that could be utilized to contribute to improving this understanding would 
involve the use of lipids that are composed of modified fatty acids. The fatty acid tails of 
the lipids could be modified by replacing the bisallylic hydrogens atoms located at 





rate of the abstraction (i.e., cleavage) of a hydrogen atom is thought to be five to ten 
times faster than the abstraction of deuterium due to the greater deuterium-carbon bond 
strength (i.e., primary isotope effect). Measurement of the lipid radicals formed during 
initiation and propagation would elucidate if the peroxidation was occurring and it would 
be anticipated that less lipid radicals would be detected in the samples containing 
deuterated lipids. 
The role of oxygen in the degradation of the lyophilized liposome samples was 
not definitively demonstrated. The effect of oxygen could be assessed by backfilling with 
dry air (21% oxygen) and the final pressure resulting from backfilling could be 
progressively increased. For example, backfilling to low, intermediate and atmospheric 
pressure with dry air would be expected to introduce increasing levels of oxygen into the 
sample vials. If the lipid degradation increased as the oxygen in the sample vials 
increased, this would suggest that oxygen is playing a role in the degradation of lipids in 
the dried state. Additionally, if samples were backfilled with dry air the subsequent 
oxygen consumption during the storage of lyophilized liposomal samples this would also 
suggest that oxygen is playing a role in the degradation of lipids in the dried state.  
Further work could also be done to better understand how the trace levels of iron 
contaminants affect dried-state lipid stability. The effect of the iron contaminants on lipid 
degradation is complex and this complexity is highlighted when the stability of DLPC 
samples during lyophilization and long term storage are compared. It was initially shown 
that the iron contaminants inherent in the pharmaceutical-grade sugars were 
predominantly in the ferric form, as indicated by the experiment involving sodium sulfite, 
and that the iron contaminants did not impact DLPC stability during lyophilization unless 
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). However during storage, the iron contaminants did 
affect the long term storage stability of DLPC as demonstrated by the experiment 
involving DTPA and DFO. It is uncertain if the iron contaminants affected DLPC 
stability during storage due to the presence of ferric ions which are able to participate in 
reactions or the increase ferrous ions, which have been shown to be more reactive, 
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resulting from the reactions involving the ferric ions. Hopefully my thesis work can 
contribute to better understanding of the factors that affect the stability of unsaturated 
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An Applied Biosystems Sciex 4000
 ® 
(Applied Biosystems; Foster City, CA) was 
used and equipped with a Shimadzu HPLC (Shimadzu Scientific Instruments, Inc.; 
Columbia, MD) and Leap auto-sampler (LEAP Technologies; Carrboro, NC). An Agilent 
Technologies, Zorbax extended-C18 50 x 4.6 mm (5 micron) column equipped with a 
column guard was used. It was heated at 40 
o
C with a flow-rate of 0.4 mL/min. The 
mobile phase consisted of A: 10 mM ammonium acetate, 0.1% formic acid in HPLC 
grade water, and B: 100% HPLC grade methanol. Electrospray was the ionization method 
and was operated in the positive ion mode (ESI+). Sample of authentic lipid were infused 
to produce an MS-MS fragmentation pattern and then degradation sample was infused to 
probe for unique mass data. Ultimately, the analytical conditions used were: i) an ion-
spray voltage of 5500 V; ii) temperature, 450 
o
C; iii) curtain gas (CUR; set at 10) and 
Collisionally Activated Dissociation (CAD; set at 5) gas were nitrogen; iv) Ion Source 
gas one (GS1) and two (GS2) were set at 30; v) entrance potential was set at 10.0 V; vi) 
quadruple one (Q1) and (Q3) were set on Unit resolution; vii) dwell time was set at 200 
msec; and viii) declustering potential (DP), collision energy (CE), and collision cell exit 
potential (CXP) are voltages (V). Compound settings were: i) DLPC: 778.7  184.1 m/z, 
DP (31), CE (65), and CXP (12) and the observed unknown degradation product at 464.2 
 122.1 m/z, DP (31), CE (15), and CXP (6). The chromatography method used was: 
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10% B for 1.0 min; brought to 95% B at 3.0 min and held for 5.5 min; brought back to 
90% A at 9.5 min and held for 1.0 min (10.5 min total run time). 
 





Figure A.2: LC/MS-MS Chromatogram: Product A & DLPC 
  











133.0089.05 111.1055.05 73.05 135.0583.10 97.10 107.1067.10 151.10
XIC of +MRM (3 pairs): 778.7/184.1 amu from Sample 6 (Sample 5 6 week 0.2 ppm) of DataSET 08152011 Nicole Batch.wiff (Turbo Spray) Max. 2.3e4 cps.
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 DOPE (18:1) DEGRADATION IN DLPC-DOPE LIPOSOMES 
 
 
Figure B.1: Degradation of DOPE when co-formulated with DLPC. A- 1:1 DLPC:DOPE 
(mol ratio) B- 9:1 DLPC:DOPE (mol ratio) 
  
Liposomes composed of DOPE (18:1) and DLPC (18:3) were formulated with 
trehalose prior to lyophilization and storage at 60°C. The DOPE concentration in the 
liposomal formulations which were investigated was 10% (9:1 DLPC:DOPE) and 50% 
(1:1 DLPC:DOPE). DOPE degradation was measured quantitatively using HPLC-UV 
and it was observed that DOPE degraded significantly over the course of the storage, 6 
weeks. The degradation of DOPE is curious since a structurally similar lipid, DOPC, 
which was also formulated with trehalose and stored at 60°C, did not degrade over the 
course of 48 weeks. The co-formulation of DOPE with DLPC, a less stable lipid which is 
prone to oxidative degradation, may have influenced the rate at which DOPE degraded. 
This explanation could be further investigated by formulating DOPC with DLPC and 
assessing the rate of DOPC degradation. Alternatively, the significant difference in 
stability could be attributed to structural differences between DOPC and DOPE; although 
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both DOPE and DOPC are singly unsaturated lipids, the headgroup of these lipids is 
different (i.e., PC versus PE). One potential explanation for the rapid degradation of 
DOPE involves DOPE facilitating the transition of the liposomal bilayer from a lamellar 
phase to a hexagonal phase thereby increasing the exposure of the fatty acid tails of the 
lipid. However, this explanation is unlikely as PC lipids, such as DLPC, prefer the 
lamellar phase and the formation of the hexagonal phase would not be expected in the 





















DLPC DEGRADATION DURING LYOPHILIZATION IN SAMPLES SPIKED 
WITH FERROUS OR FERRIC IONS 
 
 
Figure C.1: Degradation of DLPC during lyophilization in samples containing 0.2 ppm 
or 1.0 ppm ferrous or ferric ion. 
  
The degradation of DLPC was evaluated in samples which were spiked with 
ferrous (Fe
2+
) or ferric (Fe
3+
) ions and the greatest degradation was observed in the 
samples which were spiked with ferrous ion.  
 
 
 
 
 
 
